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ACUTE TOXICITY SUMMARY 
PERCHLOROETHYLENE 
(ethylene tetrachloride, tetrachloroethylene) 
CAS Registry Number:  127-18-4 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  20 mg/m³ 
Critical effect(s)  loss of normal coordination in addition to eye, nose 
and throat irritation, headache and
 light-headedness 
Hazard Index target(s)  nervous system; eyes; respiratory system 
II.  Physical and Chemical Properties (HSDB, 1993 except as noted) 
Description  colorless liquid 
Molecular formula  C2Cl4 
Molecular weight  165.83 
Density  1.6227 g/cm
3 @ 20°C 
Boiling point  121°C 
Melting point  -19°C 
Vapor pressure  18.47 mm Hg @ 25°C 
Flashpoint  unknown 
Explosive limits  unknown 
Solubility  soluble in alcohol, ether, chloroform, benzene and
 hexane; practically insoluble in water 
Odor threshold  47 ppm (geometric mean) (AIHA, 1989) 
Odor description  colorless, mildly sweet, chloroform-like odor 
Metabolites  trichloroacetic acid, trichloroethanol (ATSDR, 1992) 
Conversion factor  1 ppm = 6.78 mg/m³ @ 25°C 
III.  Major Uses or Sources 
Perchloroethylene (PCE) is widely used in the textile industry for dry-cleaning, processing, and 
finishing fabrics (HSDB, 1993).  It is also used in the degreasing of metals and as a chemical 
intermediate in the synthesis of fluorocarbons.  Electric transformers contain PCE as an insulating 
fluid and cooling gas. 
IV.  Acute Toxicity to Humans 
PCE is an eye, skin, and respiratory irritant.  The most sensitive endpoint of PCE toxicity is the 
central nervous system (Calabrese and Kenyon, 1991).  Cardiac sensitization and arrhythmias 
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have been reported following acute exposure to high concentrations of PCE (Reprotext, 1999). 
In one case report, pulmonary edema and coma followed a single exposure to an unknown 
concentration of PCE (Patel et al., 1977).  Hepatic necrosis and renal failure have been observed 
following inhalation exposure (Gosselin et al., 1984).  Symptoms associated with acute exposure 
to lower levels of PCE include tiredness, weakness, and nausea and vomiting (Reichert, 1983). 
Four human volunteers exposed to 206-235 ppm (1,400-1,600 mg/m³) PCE for 2 hours 
acclimatized to the odor within minutes (Rowe et al., 1952).  All subjects reported eye irritation 
and congestion of the frontal sinuses after 20-30 minutes of exposure.  Two of the four test 
subjects experienced dizziness.  A separate group of 4 subjects exposed to 280 ppm (1,900 
mg/m³) PCE for 2 hours reported light headedness and one subject reported nausea. 
Human subjects exposed to 100 ppm (700 mg/m³) PCE for 7 hours exhibited CNS effects as 
indicated by an abnormal modified Romberg test (a test of position sense) and symptoms 
including headache and light-headedness (Stewart et al., 1970).  Symptoms were noted after the 
first 3 hours of exposure.  Subjects exposed for 7 hours per day for 5 days reported decreased 
odor perception of PCE over the course of each exposure. 
Mild and transient hepatitis was diagnosed in a worker found unconscious following a 30-minute 
exposure to an unknown concentration of  PCE (Stewart, 1969).  Elevated serum enzymes, which 
indicate impaired liver function, were observed in a worker rendered semicomatose by exposure 
to unknown levels of PCE for 3 hours (Stewart et al., 1961).  A simulation of the exposure 
conditions in the latter case report indicated that the average estimated concentration was at least 
275 ppm (1,900 mg/m³) PCE. 
Predisposing Conditions for Perchloroethylene Toxicity 
Medical:  Persons with preexisting skin, eye, respiratory, heart, liver, kidney, skin, or 
neurolgical conditions may be more sensitive to the effects of PCE 
exposure (Reprotext, 1999).  Individuals with hypertension may be at 
increased risk of exhibiting elevated blood pressure following exposure to 
PCE. 
Chemical:  Interactions between PCE and trichloroethylene and ethyl alcohol, resulting 
in a potentiation of toxicity, have been reported (Reprotext, 1999). 
V.  Acute Toxicity to Laboratory Animals 
The LC50 for a 4-hour exposure to PCE is reported to be 5,200 ppm (35,000 mg/m³) in mice 
(Friberg et al., 1953) and 4,000 ppm (27,000 mg/m³) in rats (Carpenter et al., 1949).  Rats 
exposed to 2,300 ppm (16,000 mg/m³) PCE for 4 hours exhibited ataxia and signs similar to those 
of ethanol intoxication (Goldberg et al., 1964). 
Enlarged livers were observed at necropsy in mice exposed continuously to 9, 37, 75, or 150 ppm 
(60, 250, 510, 1,000 mg/m³) PCE for 30 days (Kjellstrand et al., 1984).  Enlargement and 
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vacuolization of hepatocytes were most pronounced in the mice exposed to 150 ppm PCE.  In a 
separate study, hepatocellular vacuolization was observed in mice at necropsy following a single 
4-hour exposure to 200 ppm (1,400 mg/m³) PCE (Kylin et al., 1963). 
Mice exposed for a single 3-hour period to 50 ppm (340 mg/m³) PCE exhibited a significant 
decrease in pulmonary bactericidal activity (type unspecified) (Aranyi et al., 1986).  No significant 
changes were observed in pulmonary bactericidal activity and mortality in mice exposed to 25 
ppm (170 mg/m³) PCE for a single 3-hour exposure or for five 3-hour exposures.  Mortality was 
significantly increased in mice exposed to 50 ppm PCE and challenged with aerosolized 
streptococci when compared to controls. 
VI.	  Reproductive or Developmental Toxicity 
A single case-control study among women employed in dry cleaning operations indicates an 
increased risk of spontaneous abortion resulting from PCE exposure (Kyyronen et al., 1989). 
However, this study is seriously limited by the small number of exposed women (247) and the 
lack of biological monitoring during the first trimester.  No studies evaluating the reproductive 
performance of occupationally exposed men were located. 
Pregnant mice exposed to 300 ppm (2,000 mg/m³) PCE for 7 hours per day on gestation days 6­
15 exhibited increased fetal resorptions and other signs of fetotoxicity including decreased fetal 
body weight and delayed ossification of skull bones and sternebrae (Schwetz et al., 1975). 
Pregnant rats similarly exposed on gestation days 6-15 exhibited a slight decrease in weight gain, 
but no statistically significant signs of fetotoxicity. 
Male guinea pigs exposed to 1,600 ppm (11,000 mg/m³) PCE for 7 hours per day for 8 exposures 
over a 10 day period exhibited degenerative changes in the germinal epithelium of the testes 
(Rowe et al., 1952). 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):   20 mg/m³ (2.9 ppm) 
Study	  Stewart et al., 1970 
Study population	  three human subjects 
Exposure method	  inhalation of 100 ppm (700 mg/m³) PCE 
Critical effects	  CNS effects as indicated by an abnormal modified 
Romberg test and symptoms including headache, 
mild irritation of the eyes, nose and throat, and 
light-headedness 
LOAEL	  700 mg/m³ 
NOAEL	  not observed 
Exposure duration	  3 h 
Extrapolated 1 hour concentration  1200 mg/m³ (700
2mg/m³* 3 h = C
2 * 1 h ) 
C - 269 - Perchloroethylene Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
  (see Table 12 for information on “n”) 
LOAEL uncertainty factor  6 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  60 
Reference Exposure Level  20 mg/m³ (20,000 mg/m³; 2.9 ppm) 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
NIOSH (1995) reports an IDLH of 150 ppm (1,017 mg/m³) based on acute inhalation toxicity 
data in humans but the level does not appear to be life-threatening based on the data cited. 
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ACUTE TOXICITY SUMMARY 
PHENOL 
(carbolic acid, phenylic acid, phenyl hydroxide) 
CAS Registry Number: 108-95-2 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  5,800 m mg/m³ 
Critical effect(s)  irritation of the eyes, nose, and throat 
Hazard Index target(s)  Eyes; Respiratory System 
II.  Physical and Chemical Properties (HSDB, 1993 except as noted) 
Description  colorless to light pink liquid 
Molecular formula  C6H5OH 
Molecular weight  94.11 
Density  1.0576 g/cm
3 @ 20°C 
Boiling point  181.75°C 
Melting point  43° C 
Vapor pressure  0.3513 mm Hg @ 25°C 
Flashpoint  79°C (closed cup) 
Explosive limits  upper = 8.6% (AIHA, 1992) 
lower = 1.7% (AIHA, 1992) 
Solubility  very soluble in alcohol, carbon tetrachloride, acetic acid
 and liquid sulfur dioxide; soluble in chloroform, ethyl
 ether, carbon disulfide; slightly soluble in water and
 benzene 
Odor threshold  0.060 ppm (geometric mean) (AIHA, 1989) 
Odor description  medicinal, acid (AIHA, 1989) 
Metabolites  o,p-hydroxylated products 
Conversion factor  1 ppm = 3.85 mg/m³ @ 25°C 
III.  Major Uses or Sources 
Phenol is obtained from coal tar and is widely used as a disinfectant for industrial and medical 
applications.  It also serves as a chemical intermediate for phenolic resins and as a solvent for 
petroleum refining (HazardText, 1993).  Approximately half of the US consumption is directly 
related to the housing and construction industries in applications such as germicidal paints and 
slimicides (HSDB, 1993). 
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IV.  Acute Toxicity to Humans 
Respiratory distress, pulmonary edema, cyanosis, muscular weakness, and loss of consciousness 
may be observed following inhalation exposure to phenol (Clayton and Clayton, 1982).  Rapidly 
absorbed through the skin, phenol is corrosive and burns any tissue with which it comes in contact 
(Clayton and Clayton, 1982).  Symptoms of acute phenol poisoning include headache, dizziness, 
photophobia, weakness, and difficulty breathing.  Death from phenol poisoning is usually due to 
respiratory failure (Clayton and Clayton, 1982).  It has been reported that ingestion of 4.8 g of 
pure phenol caused death within 10 minutes (HSDB, 1993).  Ingestion may cause oral mucosal 
burns, nausea, vomiting, and severe abdominal pain.  About 50% of the cases of acute 
overexposure to phenol are fatal (HSDB, 1993).  The oral LDLo for adults is 14 g/kg with effects 
consisting of behavioral changes and cyanosis in addition to the previously described signs. 
In a study designed to evaluate the absorption of phenol in the lungs and through the skin, eight 
volunteers were exposed either by face mask only or by skin only (accomplished by the use of a 
protective respirator) to up to 6.5 ppm phenol for 8 hours and their urinary excretion of phenol 
subsequently measured (Piotrowksi, 1971).  The concentrations of phenol to which the volunteers 
were exposed by face mask only were approximately 1.6-5.2 ppm.  The exposures included two 
30-minute breaks commencing at 2.5 and 5.5 hours after the start of exposure.  The intent of this 
study was to determine whether urinary excretion of phenol could serve as an adequate biomarker 
of dermal and inhalation exposure.  No mention of adverse effects in the volunteers was made. 
Therefore, a free-standing 8-hour NOAEL of 5.2 ppm can be determined from this study.  A 
human irritancy threshold for phenol of 182.4 mg/m³ (47 ppm) was reported by Ruth (1986). 
Predisposing Conditions for Phenol Toxicity 
Medical:  Individuals with skin, eye, respiratory, hepatic or renal diseases may be more 
susceptible to the toxic effects of phenol (Clayton and Clayton, 1982). 
Chemical:  Unknown 
V.  Acute Toxicity to Laboratory Animals 
The inhalation LC50 values for an unspecified duration of exposure in rats and mice are reported 
as 316 mg/m³ (82 ppm) and 177 mg/m³ (46 ppm), respectively (RTECS, 1993).  Smyth (1956) 
reported that rats survived an 8-hour inhalation exposure to saturated phenol vapors 
(approximately 323 ppm at 25ºC). 
A 5-minute RD50 of 166 ppm was observed in mice (DeCeaurriz et al., 1981).  Kane et al. (1979) 
report a predictable qualitative correlation between a reduction in rate of respiration in 
experimental animals (RD50) exposed to airborne sensory irritants, and the symptoms observed in 
humans exposed to the same irritants. 
Deichmann et al. (1944) observed that guinea pigs exposed to concentrations of phenol between 
25 and 50 ppm (96 and 200 mg/m³) 7 hours per day, five days per week, for four weeks displayed 
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signs of respiratory difficulty and paralysis which affected primarily the hind quarters.  Five of 
twelve animals exposed at this concentration died.  At necropsy, extensive myocardial necrosis, 
lobular pneumonia, fatty degeneration of the liver, and hepatocellular necrosis were observed in 
all animals exposed at this level.  Rabbits exposed at these same concentrations for 12 weeks did 
not exhibit any signs of discomfort, but showed similar findings at necropsy.  No indications of 
toxicity were observed in rats during a 10-week exposure to the same concentrations.  Necropsy 
findings in the rats were normal. 
Based on data on species variation in the conjugation of phenol and its metabolite quinol, the 
metabolism of phenol by rats appears to be closer to that of humans than rabbits or guinea pigs. 
The percent glucuronide and sulphate conjugates of phenol and metabolite in test species 
administered phenol orally was compared to that of conjugates excreted by humans.  The 
excretion of these conjugates by the rat was most similar to that observed in humans following 
phenol exposure (Capel et al., 1972a,b). 
Groups of 10 monkeys, 50 rats, and 100 mice were exposed to 0 or 5 ppm phenol continuously 
for 90 days (Sandage, 1961).  Hematological parameters and kidney function tests were normal. 
Additionally, the author reported no significant pathological findings at necropsy. 
VI.  Reproductive or Developmental Toxicity 
No adverse fetotoxic or teratogenic effects were found following treatment of pregnant rats with 
an intraperitoneal injection of phenol during gestation days 8-10 or 11-13 with up to 200 mg/kg 
(Minor and Becker, 1971).  In rats, radiolabeled phenol was found to equilibrate between the 
maternal and embryonic serum in equivalent levels (Gray and Kavlock, 1990). 
A dose-related reduction in fetal weight was observed following oral administration of 30, 60, and 
120 mg/kg/day phenol to pregnant rats on days 6-15 of gestation (Jones-Price et al., 1983).  No 
teratogenic or fetotoxic effects were observed. 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  1.5 ppm (5.8 mg/m³) 
Study	  Piotrowski, 1971 
Study population	  eight human volunteers 
Exposure method	  inhalation of phenol by face mask only 
Critical effects	  irritation of the eyes, nose, and throat 
LOAEL	  not determined in this study 
NOAEL	  5.2 ppm (free standing) 
Exposure duration	  8 hours 
Extrapolated 1 hour concentration  15 ppm (5.2
2ppm * 8 h) = C
2 * 1 h )
  (see Table 12 for information on “n”) 
LOAEL uncertainty factor  1 
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Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  10 
Reference Exposure Level  1.5 ppm (5.8 mg/m³; 5,800 mg/m³) 
No adverse effects were reported in 8 volunteers exposed to 5.2 ppm for 8 hours.  The study was 
designed to quantify dermal and respiratory absorption of phenol and not to detect mild irritation, 
but it contains the best available human acute inhalation exposure data.  The irritation threshold of 
47 ppm reported by Ruth (1986) does not contradict the determination of an 8-hour NOAEL of 
5.2 ppm from this study. 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
AIHA developed an ERPG-2 of 50 ppm (190 mg/m³) based on Flickinger (1976) where rats 
exposed for 8 hours to 900 mg/m³ (235 ppm) phenol exhibited tremors (Flickinger, 1976).  After 
4 hours, ocular and nasal irritation, loss of coordination, and muscular spasms were observed. 
However, the ERPG rationale incorrectly cites this study as reporting a 1-hour exposure of 312 
ppm (1,200 mg/m³) in rats.  The only acute inhalation exposure data included in the paper by 
Flickinger is exposure for 8 hours to 235 ppm as summarized above.  No uncertainty factors or 
methods of extrapolating from a 4-hour exposure to an equivalent 1-hour exposure were reported 
by AIHA. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
AIHA developed an ERPG-3 of 200 ppm (770 mg/m³).  Exposure of rats to 900 mg/m³ (235 
ppm) phenol for four hours resulted in ocular and nasal irritation, slight loss of coordination and 
muscular spasms (Flickinger, 1976).  The method used by AIHA (1992) for calculating the 
ERPG-3 value from the data was not reported.  The rationale does include the observation that no 
reports of fatalities from inhalation have been reported in humans.  No uncertainty factor is 
included for animal to human extrapolation. 
NIOSH (1995) reports an IDLH of 250 ppm.  It is based on animal inhalation toxicity data and on 
an analogy to cresol. 
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ACUTE TOXICITY SUMMARY 
PHOSGENE 
(carbon dichloride oxide; carbonyl chloride) 
CAS Registry Number: 75-44-5 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  4 m mg/m³ 
Critical effect(s)  minor damage to the lower airways 
Hazard Index target(s)  Respiratory System 
II.  Physical and Chemical Properties (HSDB, 1994 except as noted) 
Description  colorless gas 
Molecular formula  COCl2 
Molecular weight  98.92 
Density  4.05 g/L  @ 25°C 
Boiling point  8.2°C @ 760 mm Hg 
Melting point  -118°C 
Vapor pressure  1,215 mm Hg @ 20°C 
Explosive limits  upper = unknown 
lower = unknown 
Solubility  slightly soluble in water; soluble in benzene,
 glacial acetic acid, and most liquid hydrocarbons 
Odor threshold  0.9 ppm 
Odor description  musty hay, green corn (Ruth, 1986) 
Metabolites  spontaneously hydrolyzes to become HCl and CO2 
Conversion factor  1 ppm = 4 mg/m³ 
III.  Major Uses or Sources 
Phosgene is highly chemically reactive and is used as an intermediate in carbonylation reactions in 
the preparation of many organic chemicals.  It was formerly used as a potent chemical warfare 
“choking” agent.  It is currently used in the production of aniline dyes.  Occasionally, it is used in 
the manufacture of some insecticides, in the pharmaceutical industry, and in metallurgy (HSDB, 
1994).  In addition to its industrial uses, phosgene occurs as a breakdown product of chlorinated 
hydrocarbons such as tetrachloroethylene or carbon tetrachloride in the presence of short 
wavelength UV radiation (in heliarc welding of aluminum) or in the presence of hot iron and 
oxygen.  Phosgene is also a breakdown product of chloropicrin. 
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IV.  Acute Toxicity to Humans 
Much of the data on human exposures to phosgene comes from military experience, often with 
poorly characterized exposure conditions.  Exposure to phosgene can lead to delayed pulmonary 
edema, cardiorespiratory arrest, and death (AIHA, 1989).  The odor is not helpful in emergency 
situations since the odor threshold (0.9 ppm) is well above levels that may result in other toxic 
effects (Amoore and Hautala, 1983). 
No evidence exists for a systemic action of inhaled phosgene; the vasculature of the lower 
respiratory tract appears to be the critical target.  After initial exposure, irritation of the lower 
respiratory tract mucous membranes occurs due to acylation of biological macromolecules.  This 
is followed by a severe reflex vasoconstriction in the lung 2-24 hours later (Arena and Drew, 
1986).  Hypovolemia with ensuing cardiac arrest may result from massive pulmonary edema. 
Because of its low water solubility, irritation to the eyes and upper respiratory tract 
iscomparatively minor compared to the effects on the lower airways.  The lowest concentration 
reported to cause throat irritation is 3 ppm (12 mg/m³) (Henderson and Haggard, 1943).  Eye 
irritation occurs at 4 ppm (16 mg/m³), and 4.8 ppm causes cough (HSDB). 
Inhalation of 50 ppm (200 mg/m³) may be rapidly fatal (HSDB, 1994).  Phosgene acylates 
biological molecules easily, thus altering biological membrane integrity and protein structure. 
Hours after initial exposure, phosgene is hydrolyzed to HCl and CO2; the former may account for 
increased irritation to mucosal surfaces. 
Predisposing Conditions for Phosgene Toxicity 
Medical:  Individuals with underlying cardiopulmonary disease may be particularly 
susceptible to phosgene-induced pulmonary edema. 
Chemical:  Unknown 
V.  Acute Toxicity to Laboratory Animals 
An LC50 of 5.1 ppm (20.4 mg/m³) for 30 minutes is reported in mice, and an LC50 of 60-70 ppm 
(240-280 mg/m³) for 15 minutes is reported in dogs (HSDB, 1994). 
Exposure of rats to 1 ppm for 4 hours caused excess fluid and fibrin to occur in alveolar spaces 
immediately following exposure (Currie et al., 1985).  Pulmonary edema was also observed in 
guinea pigs exposed to 0.9 ppm phosgene for 5 hours (Cameron et al., 1942).  Exposure to 
phosgene at 0.2 ppm for 4 hours caused pulmonary edema in rats, mice, and hamsters, while 
guinea pigs and rabbits showed similar signs at 0.5 ppm and above (Hatch et al., 1986).  Exposure 
of rats to 5 ppm for 10 minutes resulted in pulmonary edema, while exposure to 0.15 ppm for 5.5 
hours resulted in increased protein in pulmonary lavage fluid (Diller et al., 1985). 
Diller and colleagues (1985) exposed rats to various concentrations of phosgene from 0.1 to 5 
ppm for time periods of 10 to 500 minutes.  Rats exposed to 0.1 ppm phosgene for 4 hours 
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showed histological changes in the lung, whereas no effects were seen after exposure for 1 hour. 
The histologic changes included highly vacuolated “foamy cells” in the air compartment from the 
terminal bronchioles to the alveolar ducts and broadening alveolar septae due to cellular elements 
in the septae and to edematous changes in the interstitia.  When compared to measurements of 
bronchoalveolar lavage fluid protein content, the histological changes were more sensitive 
indicators of cellular damage due to phosgene.  These histological changes indicate oxidative 
damage to the alveolar region of the lung.  Continued damage may result in permeability changes 
in the pulmonary vascular endothelium, a precursor to pulmonary edema (Pritchard, 1982). 
Pulmonary natural killer cell activity was suppressed in rats exposed to 0.5 or 1.0 ppm phosgene 
for 4 hours (Burleson and Keyes, 1989). Exposure to 0.1 ppm had no significant effect. 
Male Sprague-Dawley rats inhaled 0, 0.125, 0.25, 0.5, or 1.0 ppm phosgene for 4 hours (Currie et 
al., 1987a).  Rats exposed to 0.5 ppm or greater had significantly increased lung weight (wet and 
dry).  Lavage fluid protein was increased at 0.25 ppm and greater.  No effects were noted at 
0.125 ppm. 
Intracellular ATP levels in rats were diminished and non-protein sulfhydryl groups and associated 
antioxidant enzymes were increased in lung tissue following acute phosgene exposure (Currie et 
al., 1985; Currie et al., 1987b; Jaskot et al., 1991). 
Female CD-1 mice inhaled 0.1, 0.15, 0.25, or 0.5 ppm phosgene for 4 hours (Illing et al., 1988). 
No changes in body weight, liver weight, or cytochrome P450 levels were noted at any 
concentration.  Exposures to 0.15 ppm or greater significantly increased phenobarbitol-induced 
sleeping time. 
Winternitz et al. (1920) describe the pathology associated with phosgene exposure in animals. 
Pathological evaluation of dogs exposed for 30 minutes to 44 to 120 ppm (176 to 480 mg/m
3) 
revealed acute emphysema and atelectasis, mottled lung appearance, fluid filled trachea, 
edematous larynx, and necrosis of the bronchioles.  In other species, phosgene exposure was 
associated with severe lung edema and inflammatory changes which begin tin the bronchioles and 
extend into the alveoli.  For the rat and monkey a concentration of 80 mg/m
3 was lethal at 30 
minutes (no sample size reported). 
VI.  Reproductive or Developmental Toxicity 
No evidence exists to suggest that maternal phosgene exposure directly affects reproduction or 
fetal development. 
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VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour  exposure) 
Reference Exposure Level (protective against mild adverse effects):  4 m mg/m
3 
Study  Diller et al., 1985
 
Study population  14 rats
 
Exposure method  inhalation (for 10 to 500 minutes)
 
Critical effects  histologic changes in the lungs
 
LOAEL  0.1 ppm for 4 hours
 
NOAEL  0.1 ppm (0.4 mg/m³) for 1 hour
 
Exposure duration  1 hour
 
Extrapolated 1 hour concentration  0.1 ppm
 
LOAEL uncertainty factor  1
 
Interspecies uncertainty factor  10
 
Intraspecies uncertainty factor  10
 
Cumulative uncertainty factor  100
 
Reference Exposure Level  1 ppb (4 mg/m³)
 
The 0.1 ppm 1-hour NOAEL and 4-hour LOAEL is generally consistent with the findings of a 
number of other studies.  Burleson and Keyes (1989) observed a 4-hour rat NOAEL of 0.1 ppm 
for suppression of pulmonary natural killer cell activity.  Jaskot et al. (1991) reported a 4 hour rat 
LOAEL of 0.1 ppm for elevated activities of several pulmonary enzymes.  Hatch et al. (1986) and 
Currie et al. (1987a) noted 4-hour rat NOAELs of 0.1 ppm and 0.125 ppm, respectively, for 
increased lavage fluid protein.  Illing and associates (1988) observed a 4 hour mouse NOAEL of 
0.1 ppm for increased phenobarbitol-induced sleeping time. 
Level Protective Against Severe Adverse Effects 
Exposure of 20 mice, 10 rats, 10 guinea pigs, 10 rabbits, 2 cats, and 2 goats to 0.2 ppm phosgene 
for 5 hours per day for 5 days resulted in no deaths and in minimal pulmonary edema in the 
majority of the animals (Cameron and Foss, 1941; Cameron et al., 1942).  In a few animals (1 rat, 
1 mouse, 1 rabbit, and 3 guinea pigs) massive pulmonary edema was noted.  The NRC (1986) 
proposed an EEGL of 0.2 ppm (0.8 mg/m³) and the AIHA (1989) proposed an ERPG-2 level of 
0.2 ppm.  The EEGL value includes extrapolation from 5-hour data assuming an exponent (n) of 
1 for the equation C
n * t = k (Rinehart and Hatch, 1964).  Additional uncertainty factors (to 
account for differences between animals and humans, for approximation of a NOAEL, and for 
consideration of sensitive individuals) were not included.  Hatch et al. (1986) reported pulmonary 
edema in several laboratory species after 4-hour exposures to 0.2 ppm phosgene, indicating that a 
lower value would be required to protect the general public. 
Gross et al. (1965) reported that the lowest exposure level of phosgene, which produced 
moderate pneumonitis in rats, was 0.8 ppm.  We will consider this level of 0.8 ppm for 1 hour as a 
NOAEL for severe pneumonitis, a severe adverse effect.  Applying an interspecies uncertainty 
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factor of 10 and an intraspecies uncertainty factor of 10 results in a cumulative uncertainty factor 
of 100 and a level protective against severe adverse effects for 1 hour of 8 ppb (32 mg/m
3).  As 
indicated above, this lower value is needed to provide protection for the general public. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
Rats exposed to 1.7 ppm phosgene for 2 hours had mild to severe pneumonitis 2 days following 
exposure (Rinehart and Hatch, 1964; Gross et al., 1965).  Exposure of rats to 0.5 ppm for 2 
hours resulted in changes in alveolar epithelium leading to decreased diffusing capacity of the 
lungs (Gross et al., 1965).  The AIHA (1989) concluded that a 1-hour exposure to phosgene 
below 1.0 ppm (4 mg/m³) is not life-threatening.  NIOSH (1995) lists an IDLH of 2 ppm.  A 30­
minute LC50 in mice of 5.1 ppm (HSDB, 1994) suggests that levels lower than 2 ppm are required 
to protect the general public from life-threatening effects. 
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ACUTE TOXICITY SUMMARY 
PROPYLENE OXIDE 
(1,2-propylene oxide, methyl ethylene oxide, propene oxide) 
CAS Registry Number: 75-56-9 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  3,100 m mg/m³ 
Critical effect(s)  dyspnea in mice 
Hazard Index target(s)  Eyes; Respiratory System;
 Reproductive/developmental 
II.  Physical and Chemical Properties  (HSDB, 1994 except as noted) 
Description  colorless liquid 
Molecular formula  C3H6O 
Molecular weight  58.08 
Density  0.83 g/cm
3 @ 20°C 
Boiling point  34.23°C 
Melting point  -112.13°C 
Vapor pressure  445 mm Hg @ 20°C 
Flashpoint  -19.44°C, closed cup 
Explosive limits  2.8% - 37% 
Solubility  soluble in water, miscible in acetone, benzene, carbon
 tetrachloride, methanol, ether 
Odor threshold  35 ppm (geometric mean) (AIHA, 1989) 
Odor description  sweet (AIHA, 1989) 
Conversion factor  1 ppm = 2.38 mg/m³ @ 25°C 
III.  Major Uses or Sources 
Propylene oxide is used as a fumigant such as in the sterilization of packaged foods.  It is also 
used as a chemical intermediate in the production of propylene glycol and glycol ethers and as a 
solvent.  Propylene oxide is used in the preparation of surfactants and oil demulsifiers. 
IV.  Acute Toxicity to Humans 
Propylene oxide is a primary irritant of the eyes and of the upper and lower respiratory tracts 
(HSDB, 1994).  Mild CNS depression, indicated by incoordination, ataxia, and depression, are 
also reported effects of propylene oxide exposure. 
C - 285 - Propylene Oxide Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
In a case-report, an accidental 15-minute human exposure to 1,400-1,500 mg/l (5.9 x 10
5 ­
6.3 x 10
5 ppm) propylene oxide vapor was reported to result in irritation of the eyes and a burning 
sensation behind the sternum (Beljaev et al., 1971).  Late onset symptoms included headache, 
asthenia, and diarrhea.  Recovery was reported to be complete the following day. 
Predisposing Conditions for Propylene Oxide Toxicity 
Medical:  Persons with existing eye, skin, cardiopulmonary, or neurological 
conditions may be more sensitive to the toxic effects of propylene oxide 
exposure (Reprotext, 1999). 
Chemical:  Persons consuming large quantities of foods fumigated with propylene 
oxide may be more sensitive to toxic effects following inhalation exposure 
to propylene oxide (Reprotext, 1999). 
V.  Acute Toxicity to Laboratory Animals 
The 4-hour LC50s for mice and rats are reported as 1,740 and 4,000 ppm (4,100 and 9,500 
mg/m³) propylene oxide, respectively (Jacobsen et al., 1956).  The LD50 for propylene oxide 
administered by stomach tube is reported as 1,140 mg/kg in rats and 690 mg/kg in guinea pigs 
(Smyth et al., 1941). 
Rats (5 of each sex) were exposed to 1,277, 2,970, 3,794, and 3,900 ppm (3,040, 7,070, 9,030, 
and 9,300 mg/m³) propylene oxide for 4 hours (NTP, 1985).  Dyspnea and red nasal discharge, 
followed by death, were observed in animals in the three highest exposure groups. 
In the same experiment, ten mice (5 of each sex) were exposed to 387, 859, 1,102, 1,277, and 
2,970 ppm (920, 2,040, 2,600, 3,040, and 7,070 mg/m³) propylene oxide for 4 hours.  Dyspnea 
was observed in all exposed groups.  Narcosis was observed in those mice exposed to 1,102 or 
1,277 ppm propylene oxide.  Lacrimation was observed in mice exposed to 1,277 ppm propylene 
oxide.  Treatment-related lethality was observed in the three highest exposure groups.  While 
deaths were not observed following exposure to 859 ppm, one female mouse died 6 days 
following exposure to 387 ppm.  The authors suggest that the death observed at 387 ppm was not 
treatment related.  No gross pathologic effects were observed in any of the exposed mice at 
necropsy. 
No studies of the metabolism of propylene oxide were located.  Epichlorohydrin, structurally 
similar to propylene oxide, was found to be readily absorbed in the gastrointestinal and respiratory 
tracts (USEPA, 1987).  By analogy to other structurally similar compounds, propylene oxide is 
likely to be distributed to the kidneys, liver, pancreas, adrenal glands, and spleen.  Glutathione 
conjugates and carbon dioxide are likely metabolites to be found in the urine and expired air of 
animals exposed to propylene oxide. 
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VI. 	 Reproductive or Developmental Toxicity 
Female rats exposed to 500 ppm (1,200 mg/m³) propylene oxide 7 hours per day, 5 days per week 
for three weeks prior to mating exhibited a significant reduction in the number of corpora lutea, 
implants, and live fetuses compared to rats exposed from days 7-16 or 1-16 of gestation (Hardin 
et al., 1983).  Fetal effects included a significant reduction in fetal body weight and crown-rump 
length; wavy ribs and reduced skeletal ossification were also noted in propylene oxide exposed 
litters.  Maternal toxicity, indicated by a statistically significant decrease in body weight gain and 
increased kidney weight, was observed.  The same study exposed rabbits in a similar manner to 
the same concentration; no significant reproductive or developmental effects were observed. 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):   1.3 ppm (3.1 mg/m³) 
Study  National Toxicology Program, 1985 
Study population  10 mice (5 per sex) 
Exposure method  inhalation in a chamber 
Critical effects  dyspnea (1 death 6 days post exposure) 
LOAEL  387 ppm 
NOAEL  not observed 
Exposure duration  4 hours 
Extrapolated 1-hour concentration  774 ppm (387
2ppm * 4 h = C
2 * 1 h )
  (see Table 12 for information on “n”) 
LOAEL uncertainty factor  6 
Interspecies uncertainty factor  10 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  600 
Reference Exposure Level  1.3 ppm (3.1 mg/m³; 3,100 mg/m³) 
Mice (five of each sex) were exposed to 387 ppm or 859 ppm propylene oxide for 4 hours. 
Dyspnea was observed in all exposed groups.  No gross abnormalities were noted at necropsy. 
The LOAEL for dyspnea (in this case considered an irritant, mild adverse effect) is 387 ppm 
propylene oxide.  (One female mouse died 6 days following exposure to 387 ppm propylene 
oxide.  Because no deaths were observed in the 859 ppm exposure group, it is plausible that the 
observed death was not treatment related.) 
NTP (1985) reports that propylene oxide acts as an irritant only at the site of administration, the 
nose in this case.  Therefore, the dyspnea reflects nasal irritation, a mild effect.  Necropsy findings 
in the NTP study of animals following both acute and chronic exposures support this assumption. 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
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Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
NIOSH (1995) lists a revised IDLH for propylene oxide of 400 ppm based on acute inhalation 
toxicity/lethality data in mice and dogs.  The dog 4­hour LCLO is 2,005 ppm and the mouse 4­hour 
LC50 is 1,740 ppm (Jacobson et al. 1956).  This value of 400 ppm appears low for a level 
protective against life-threatening effects based on the case report of complete recovery from a 
600,000 ppm exposure for 15 minutes (Beljaev et al., 1971). 
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ACUTE TOXICITY SUMMARY 
SODIUM HYDROXIDE 
(caustic soda, caustic flake, white caustic, soda lye, lye, sodium hydrate) 
CAS Registry Number: 1310-93-2 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation Reference Exposure Level  8 m mg/m³ 
Critical effect(s)  subjective complaints of eye, skin, and
 respiratory irritation in occupationally
 exposed workers 
Hazard Index target(s)  Eyes; Skin; Respiratory System 
II.  Physical and Chemical Properties  (HSDB, 1993) 
Description  colorless solid 
Molecular formula  NaOH 
Molecular weight  40.01 
Density  2.13 g/cm
3 at 25°C 
Boiling point  1,390°C 
Melting point  318.4°C 
Vapor pressure  1 mm Hg @ 739°C 
Flashpoint  not applicable 
Explosive limits  not applicable 
Solubility  soluble in water, alcohol and glycerine 
Odor threshold  not applicable 
Metabolites  not applicable 
Conversion factor  not applicable (when dust) 
III.  Major Uses and Sources 
Sodium hydroxide (NaOH) is produced primarily by the electrolysis of sodium chloride solutions 
and also from sodium carbonate.  Sodium hydroxide is used in the manufacture of chemicals, 
rayon, soap and detergents, pulp and paper, petroleum products, cellophane, textiles and 
explosives, in etching and electroplating, in metal descaling, and in batteries. 
IV.  Acute Toxicity to Humans 
Sodium hydroxide is a strong irritant and has a marked corrosive action on all body tissues 
regardless of the route of exposure (Reprotext, 1993).  It is also more irritating than equivalent 
amounts of strong acid. 
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Controlled dermal exposures with concentrated sodium hydroxide have resulted in intercellular 
edema, erythema, decomposition of keratin material, and destruction of the epidermis (NIOSH, 
1975).  There may be a latency period between dermal contact and the onset of a sensation of 
irritation or burning.  Exposure to sodium hydroxide mist may cause multiple small burns and 
temporary hair loss. 
Sodium hydroxide in contact with the eyes can result in ulceration, perforation, and opacification 
of the cornea, leading to blindness (Grant, 1986; NIOSH, 1975). 
Oral ingestion of sodium hydroxide can result in burns to the lips, tongue, oral mucosa, and 
esophagus (Medical Management, 1993).  Sodium hydroxide has been implicated in the 
production of esophageal cancer at the site of esophageal strictures resulting from accidental 
ingestion (Appelqvist et al., 1980).  These cancers are believed to be the consequence of scar 
formation and tissue destruction rather than from a direct carcinogenic effect of sodium hydroxide 
(NIOSH, 1975). 
The effects of inhalation exposure to sodium hydroxide have not been reliably studied.  Some 
cases of acute respiratory symptoms following exposure with nose and throat irritation, chest 
pains, and shortness of breath have been reported (NIOSH, 1974).  In an unreferenced comment, 
Patty (1949) remarked that exposure to 2 mg /m³ NaOH in air is noticeably, but not excessively, 
irritating.  Ott et al. (1977) stated that workers exposed to sodium hydroxide levels estimated to 
range from 0.5 to 2 mg/m³ time-weighted average (TWA) experienced nasal, skin, and, to a lesser 
extent, respiratory irritation.  The duration of exposure prior to development of symptoms was 
not mentioned.  Also, the 8-hour TWA concentrations are based on a one-time measurement. 
Workers exposed to 0.01 to 0.7 mg/m³ heated sodium hydroxide, in addition to other solvents, 
experienced upper respiratory tract irritation (Hervin and Cohen, 1973).  Heating may increase 
the toxicity of sodium hydroxide (NRC, 1984). 
Case reports exist in the literature of irreversible obstructive lung disease following chronic 
occupational exposure as well as after a one-time, high-level exposure to sodium hydroxide 
(Hansen and Isager, 1991; Rubin et al., 1992). 
Predisposing Conditions for Sodium Hydroxide Toxicity 
Medical:  Persons with skin, eye or respiratory conditions may be more sensitive to 
the effects of sodium hydroxide (Reprotext, 1999).  Persons with glaucoma 
should not work around mists or aerosols of sodium hydroxide since it can 
raise eye pressure (Reprotext, 1993). 
Chemical:  Persons exposed simultaneously to ammonium chloride, other irritants, or 
alkalis may be more sensitive to the effects of sodium hydroxide (Dluhos et 
al., 1969). 
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V.	  Acute Toxicity to Laboratory Animals 
Application of sodium hydroxide to the skin of rats and mice has produced severe irritation 
leading to necrosis and death (NIOSH, 1975).  Topical ocular application of sodium hydroxide in 
rabbits has resulted in ulceration, perforation, and corneal necrosis (NIOSH, 1975; Grant, 1986). 
Corneal opacification, vascularization, and an increase in intraocular pressure have also been 
observed.  Species differences in the degree of irritancy and recovery after eye application have 
been noted (Grant, 1986).  The eyes of monkeys are less sensitive to sodium hydroxide and 
recover more completely than rabbits’ eyes. 
In rats exposed by inhalation to an unknown concentration of sodium hydroxide produced from 
an aerosolized 40% solution for 30 minutes twice daily for 2.5 months, lung examination revealed 
alveolar wall thickening with cell proliferation and congestion (Dluhos et al., 1969).  Ulceration 
and flattening of the bronchial epithelium and proliferation of lymphadenoid tissue were also 
reported.  Undescribed, isolated tumors were observed in 3 of 10 animals.  In another study, 
inhalation exposure twice weekly for one month to an aerosol produced from a 40% sodium 
hydroxide solution resulted in the deaths of all 27 rats, predominantly from bronchopneumonia 
(Vyskocil et al., 1966).  Exposure to an aerosol produced from a 20% solution of sodium 
hydroxide produced dilatation and destruction of alveolar septae.  Although no effects were 
observed in the group exposed to a 10% solution, in rats exposed to aerosolized 5% sodium 
hydroxide, bronchial dilatation and mucus membrane degeneration were observed, which suggest 
a poor dose-response relationship in this study. 
VI. 	 Reproductive or Developmental Effects 
No studies are available regarding the reproductive or developmental effects of sodium hydroxide 
in humans. 
Sodium hydroxide injected into the amniotic fluid of rats at 0.001 M on day 13 of gestation was 
not teratogenic but was slightly embryotoxic (Dostal, 1973). 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  0.008 mg/m³ (8 m mg/m³) 
Study  Ott et al., 1977 
Study population  291 workers in sodium hydroxide production 
Exposure methods  occupational exposure 
Critical effects  subjective reports of mild to moderate-severe
 irritation of the eyes and skin; mild respiratory
 irritation 
LOAEL  0.5 mg/m³ 
NOAEL  not reported 
Exposure duration  8-hour time-weighted average 
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Extrapolation to 1 hour  not used 
LOAEL uncertainty factor  6 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  60 
Reference Exposure Level  0.008 mg/m³ (8 mg/m³) 
Uncertainty factors were applied to the lowest concentration at which symptoms were reported 
(0.5 mg/m³).  The reported irritation was mild to moderate-severe, which indicates that the 
irritation was beyond mild irritation although it was below severe classification.  Because sodium 
hydroxide aerosols can readily undergo reaction with carbon dioxide to form sodium carbonate, a 
standard for sodium carbonate should also be developed (Cooper et al., 1979). 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
In an unreferenced comment, Patty (1949) stated that exposure to 2 mg/m³ sodium hydroxide in 
air would cause noticeable, but not excessive respiratory irritation.  Exposure to sodium 
hydroxide estimated to be as high as 2 mg/m³ TWA caused nasal and skin irritation, especially in 
areas of the plant where temperatures were higher (Ott et al., 1977). 
The NRC (1984) used their expert judgment in determining an EEGL of 2 mg/m³, therefore it 
does not follow OEHHA’s methodology.  No margin of safety was applied in the derivation of the 
1-hour EEGL. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
NIOSH (1995) reports an IDLH of 10 mg/m³.  It is based on Ott et al. (1977).  Workers exposed 
to 2 to 8 mg/m³ “caustic dust” experienced irritation of the respiratory system.  NIOSH states that 
“This may be a conservative value due to the lack of relevant acute toxicity data for workers 
exposed to concentrations above 8 mg/m³.” 
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ACUTE TOXICITY SUMMARY 
STYRENE 
(vinyl benzene; phenylethylene; cinnamene; styrol; vinylbenzol) 
CAS Registry Number: 100-42-5 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  21,000 m mg/m³
 
Critical effect(s)  eye and upper respiratory irritation
 
Hazard Index target(s)  Eyes; Respiratory System;

 Reproductive/developmental 
II.  Physical and Chemical Properties  (Vainio and Hietanen, 1987 except as noted) 
Description  colorless liquid
 
Molecular formula  C8H8
 
Molecular weight  104.14
 
Density  0.902 g/cm
3 @ 20°C
 
Boiling point  145.2°C
 
Melting point  -30.6°C
 
Vapor pressure  6.45 mm Hg @ 25°C
 
Flashpoint  31°C (closed cup) (ATSDR, 1992)
 
Explosive limits  upper = 6.1% by volume in air
 
lower = 1.1% by volume in air (ATSDR, 1992) 
Solubility  soluble in ethanol, ether, acetone, benzene, and
 petroleum ether; sparingly soluble in water 
Odor threshold  1.36 mg/m³ (0.32 ppm) (Amoore and Hautala, 1983) 
Odor Description  sweet, sharp odor (Amoore and Hautala, 1983) 
Metabolites  styrene 7,8-oxide, styrene glycol, mandelic acids,
 phenylglyoxylic acids (Leibman and Ortiz, 1970;
 Sedivec et al., 1984) 
Conversion factor  1 ppm = 4.2 mg/m³ 
III.  Major Uses or Sources 
Styrene is produced by the dehydrogenation of ethylbenzene in the presence of polymerization 
inhibitors (Vainio and Hietanen, 1987).  It is used in the plastics industry as a solvent for synthetic 
rubber and resins, as a starting material in the manufacture of emulsifying agents, in the 
manufacture of synthetic rubber and polystyrene, and in the production of propylene oxide 
(Vainio and Hietanen, 1987). 
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IV.  Acute Toxicity to Humans 
Styrene may irritate the eyes and mucous membranes and may be toxic to the central nervous 
system (IARC, 1979).  Immediate eye and throat irritation, increased nasal mucus secretion, 
listlessness, impairment of balance, and drowsiness followed by unsteadiness, muscle weakness, 
and depression were reported in a study of 2 human volunteers exposed to 800 ppm 
(3,360 mg/m³) styrene for 4 hours (Carpenter et al., 1944).  Other symptoms include a feeling of 
being “lightheaded” or “drunk” (Lorimer et al., 1976). 
In an exposure chamber study, volunteer subjects complained of an objectionably strong odor 
when exposed to 200-400 ppm (840-1,680 mg/m³) styrene; exposure to 60 ppm (252 mg/m³) 
resulted in detectable odor but no irritation (Wolf et al., 1956).  The duration of exposure and 
number of subjects were not specified.  Investigators at a fiberglass plant could not withstand 
more than 1-2 minute exposure to concentrations of 500-800 ppm styrene (Götell et al., 1972). 
However, workers exposed to this concentration of styrene for hours complained of only mild to 
moderate complaints of irritation, suggesting that tolerance may have developed. 
Stewart et al. (1968) found eye and throat irritation in 3 out of 6 volunteers exposed to 99 ppm 
(416 mg/m³) styrene for 20 minutes.  No symptoms were reported in 3 subjects after exposure to 
51 ppm for 1 hour.  Exposure of these subjects to 376 ppm (1,579 mg/m³) styrene for 25 minutes 
resulted in nausea, significant discomfort, and an abnormal Romberg test, indicative of cerebellar 
dysfunction.  Significant decrements were noted in 3/5 subjects in other tests of coordination and 
manual dexterity at 50 minutes.  Exposure to 216 ppm or less for up to 1-hour did not cause 
measurable impairment of coordination and balance. 
The neurotoxic effects mediated by styrene consist of slowing in sensory, but not motor, nerve 
conduction velocity and CNS depression (Cherry and Gautrin, 1990).  Reaction time was 
significantly impaired in 12 males exposed to 350 ppm (1,470 mg/m³) styrene for 30 minutes, 
whereas no significant impairment was observed at 250 ppm (1,050 mg/m³) or lower (Gamberale 
and Hultengren, 1974).  In this study, no effects on perceptual speed or manual dexterity were 
detected.  In another study of 12 workers exposed during the workday to 110 mg/m³ (26 ppm), 
Edling and Ekberg (1985) measured reaction time before and after work and found no significant 
differences.  Other non-CNS symptoms were reported in a neuropsychiatric questionnaire 
completed by the subjects. 
Abnormal electroencephalograms were correlated with urinary levels of the styrene metabolite, 
mandelic acid, of 700 mg/l or higher in workers exposed to styrene (Harkonen et al., 1978). 
Consumption of ethanol has been shown to decrease formation of the metabolites mandelic and 
phenylglyoxylic acid in human volunteers exposed to 420 mg/m³ (100 ppm) styrene for 8 hours 
(Cerny et al., 1990).  Lowered levels of these metabolites have been associated with a reduced 
risk of CNS disturbances in volunteer workers (Cherry and Gautrin, 1990).  Co-exposure to 
inhaled acetone was reported to alter cytochrome-P450 enzymes as measured by altered urinary 
steroid metabolites and glucaric acid in workers who consumed moderate amounts of alcohol 
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(Dolara et al., 1983).  However, the clinical significance of the presence of these compounds in 
the urine is unknown. 
Styrene is bioactivated to styrene 7,8-oxide, a reactive metabolite which binds to tissue proteins, 
acts as a hapten, and elicits contact allergy in some individuals (Sjoborg et al., 1984).  Analyses of 
styrene oxide adducts bound to human serum albumin have been used as biomarkers for exposure 
to styrene (Rappaport et al., 1993).  In a study comparing 9 styrene-exposed workers with 24 
healthy controls, hematocrit, blood lead levels, and delta-aminolevulinate dehydrase (ALA-D) 
levels were measured (Fujita et al., 1987).  The workers were exposed to at least 210 mg/m³ 
(50 ppm) styrene for 7 days.  Styrene oxide was shown to inhibit the formation of ALA-D, an 
important enzyme in heme biosynthesis, in these workers.  Styrene oxide is also known to bind 
covalently to DNA in vitro (Hemminki and Hesso, 1984). 
Two subjects with occupational asthma due to prior exposure to styrene were exposed to 15 ppm 
(63 mg/m³) styrene in a chamber (Moscato et al. (1987).  Immediate bronchoconstriction was 
observed in both subjects while a late rash was also observed in one of the subjects. 
Predisposing Conditions for Styrene Toxicity 
Medical:	  Asthmatics may be more sensitive to adverse pulmonary effects from styrene 
exposure (Moscato et al., 1987). 
Chemical: 	 Ethanol consumption and acetone inhalation may inhibit the metabolism and 
clearance of styrene (Cerny et al., 1990; Dolara et al., 1983; Elovaara et al., 1990). 
V.  Acute Toxicity to Laboratory Animals 
The irritant and central nervous system (CNS) depressant effects of styrene in humans are 
consistent with the acute effects observed in experimental animals (Bond, 1989). 
Bonnet et al. (1979; 1982) determined a 6 hour LC50 in rats and mice of 4,618 ppm (95% 
confidence interval, 4,399-4,894 ppm) and 2,429 ppm (95% confidence interval, 2,353-2,530 
ppm), respectively.  Shugeav (1969) also determined the LC50 in rats and mice.  In rats the 4 hour 
LC50 was 2,810 ppm (95% confidence interval, 2,452-3,214 ppm), and in mice the 2 hour LC50 
was 5,000 ppm (95% confidence interval, 4,238-5,905 ppm).  Jeager et al. (1974) estimated the 4 
hour LC50 in rats to be 2,700 ppm.  In other acute lethality studies, 2 of 6 rabbits died following 4 
hour exposure to 4,000 ppm styrene (Union Carbide Corp., 1957). 
Lundberg et al. (1986) could not determine an LC50 in rats because the concentrations required 
for lethality in a 4 hour exposure exceeded the vapor saturation point.  No animals died as a result 
of a 4 hour exposure to 7,904 ppm styrene while 4/10 rats died when exposure at this 
concentration was extended to 8 hours. 
Inhalation of 1,300 ppm (6,000 mg/m³) by rats and guinea pigs resulted in immediate irritation and 
lacrymation (Spencer et al., 1942).  No deaths occurred from exposure to 10,000 ppm styrene for 
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1 hour.  However, exposure to this concentration for 3 hours resulted in 100% mortality in both 
species.  This concentration of styrene was the highest that the researchers could attain at room 
temperature without the chemical condensing out of the atmosphere.  At 5,000 ppm, a 100% 
survival rate was observed following exposure of rats and guinea pigs for 2 and 3 hours, 
respectively.  One-hundred percent mortality was observed at this concentration in both species 
following 8 hour exposure.  Immediate deaths were due to CNS depression.  However, delayed 
deaths occurred due to pulmonary edema and hemorrhage which frequently developed as a result 
of styrene’s acute lung irritant action. 
In a study by Morgan et al. (1993a), B6C3F1 mice (36 mice/sex/dose) were exposed to 125, 250, 
or 500 ppm of styrene 6 hours/day for 3 days.  Seven of 72 mice died or were terminated 
moribund following one 6-hour exposure to 500 ppm.  Necropsy of dead or dying mice revealed 
livers engorged with blood.  Severe congestion and necrosis of the liver was observed under 
microscopic examination.  Exposure to both 250 and 500 ppm styrene was associated with 
progressive degenerative and necrotic hepatocellular changes after one 6 hour exposure.  There 
were no significant histologic lesions in mice exposed to 125 ppm styrene.  While the liver was 
identified as the major target organ in mice, the authors indicated that styrene’s CNS depressant 
action also likely contributed to the overall toxicity.  Another inhalation study by this research 
group determined that B6C3F1 mice are more sensitive to styrene induced hepatotoxicity than 
other common mouse strains, and that kidney toxicity was not seen in any strain of mice 
investigated following styrene exposure (Morgan et al., 1993b). 
Morgan et al. (1995) conducted additional studies to investigate mouse strain and gender 
differences in susceptibility to hepatotoxicity caused by repeated exposure to styrene at 
concentrations that do not cause metabolic saturation.  Male and female B6C3F1 and Swiss mice 
(8 weeks old) were exposed to 0, 150, or 200 ppm styrene for 6 hr/day, 5 days/week, for up to 2 
weeks.  Changes in body and liver weights, serum enzyme levels, liver histopathology, and total 
liver glutathione (GSH) were evaluated after 2, 3, 5, and 10 exposures (six mice/sex/strain/time 
point/concentration).  Serum alanine aminotransferase (ALT) and sorbitol dehydrogenase (SDH) 
levels were significantly elevated only in female B6C3F1 mice after 3 exposures to 200 ppm 
styrene; enzyme levels had returned to control levels when measured after 5 and 10 exposures. 
Degeneration and coagulative necrosis of centrilobular hepatocytes were observed in female 
B6C3F1 mice exposed 2, 3, and 5 days to 150 or 200 ppm styrene; incidences of these lesions 
were greater in the 200 ppm than in the 150 ppm dose group.  After 10 days of exposure to 150 
or 200 ppm styrene, hepatocellular lesions had resolved, although a residual chronic inflammation 
was present in livers of most female B6C3F1 mice. 
The acute inhalation toxicity adverse effects in mice do not appear to be consistent with adverse 
effects seen in humans and other animal species.  In research by Mendrala et al. (1993) and a 
review by Sumner and Fennell (1994), comparison of the metabolic fate of styrene and its toxic 
metabolite, styrene oxide, in mice, rats, and humans showed that mice are more sensitive than rats 
and humans to the hepatotoxic effects of styrene.  Based on P450 enzyme kinetics (the primary 
enzymes responsible for metabolizing styrene to styrene oxide) and the relative liver and body 
size, the mouse had the greatest capacity to form styrene oxide from styrene.  In mice exposed to 
relatively low levels of styrene (250 to 500 ppm), the blood concentration of the metabolite 
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styrene oxide rises steeply, potentially resulting in hepatotoxicity and mortality.  This metabolic 
phenomenon does not occur in rats or humans.  In addition, hepatotoxicity has not been reported 
for rats, and there have not been epidemiological findings of hepatotoxicity in humans exposed to 
styrene. 
Sumner at al. (1997) compared the metabolism and hepatotoxicity (mice only) of styrene in male 
B6C3F1 mice, CD-1 mice, and F344 rats to evaluate mechanisms of toxicity.  Rats and mice were 
exposed to 250 ppm styrene for 6 h/day for 1 to 5 days.  Mortality and increased serum ALT 
activity were observed in mice but not in rats.  Hepatotoxicity in B6C3F1 mice was characterized 
by severe centrilobular congestion after one exposure followed by acute centrilobular necrosis. 
Hepatotoxicity was delayed by 1 day in CD-1 mice, and the increase in ALT and degree of 
necrosis were less than in B6C3F1 mice.  After exposure to (unlabeled) styrene for 0, 2, or 4 
days, rats and mice were exposed to [7-
14C]-styrene (60 mCi/mmol) for 6 h.  Most styrene-derived 
radioactivity was excreted in urine; the time-course indicated that rats and CD-1 mice eliminated 
radioactivity at a faster rate than B6C3F1 mice following a single 250 ppm exposure, consistent 
with a greater extent of liver injury for B6C3F1 mice.  The elimination rate following 3 or 5 days 
of exposure was similar for rats and the two mouse strains.  After three exposures, the total 
radioactivity eliminated was elevated over that measured for one exposure for both mouse strains. 
An increased excretion of metabolites on multiple exposure is consistent with the absence of 
ongoing acute necrosis following 4 to 5 daily exposures.  The data indicate that an induction in 
styrene metabolism occurs after multiple exposures. 
Pretreatment of rats with acetone potentiated pulmonary toxicity, measured by decreased lung 
glutathione and cytochrome-P450 activity following inhalation of 2,100 mg/m³ styrene vapor 5 
hours/day for 3 days (Elovaara et al., 1990). 
Styrene has been shown to suppress antibody responses and to enhance hypersensitivity responses 
in mice after multiple administrations of 20 mg/kg for 5 days (Dogra et al., 1989). 
VI.  Reproductive or Developmental Toxicity 
There is no direct evidence for human reproductive or developmental toxicity from styrene 
exposure. 
Murray et al. (1978) found no teratogenesis or reproductive impairment in rats or rabbits inhaling 
styrene concentrations up to 600 ppm (2,520 mg/m³) throughout critical days of gestation. 
Decreased maternal body weight gain was observed in rats but not rabbits.  Other studies in 
rodents have supported this finding (Daston et al., 1991; Srivastava et al., 1989).  A 
comprehensive review on the subject could find no evidence for reproductive and developmental 
toxicity in experimental animals or humans (Brown, 1991).  Likewise, a review of epidemiological 
studies could find no evidence of reproductive health effects in women due to occupational 
exposure to styrene (Lindbohm, 1993). 
Kishi et al. (1995) exposed pregnant Wistar rats via inhalation to 0, 50, or 300 ppm styrene for 6 
h/day during gestation days 7 to 21.  Offspring were evaluated in several neurobehavioral tests. 
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Initial results with a few litters showed significant dose-dependent effects in tests performed pre­
weaning (surface righting, pivoting locomotion, and bar holding) and in tests performed post-
weaning (motor coordination, open-field behavior, and motor activity).  Exposure to 50 ppm 
styrene caused disturbances in motor coordination and delayed some motor and reflex 
developments, and 300 ppm led to changes in open-field behavior, increases in spontaneous 
activity, and delay in neurobehavioral developments.  Exposure of dams to styrene did not clearly 
affect the learning behavior of the offspring.  Age played a role in the differences in styrene’s 
effects on neurobehavioral function.  At 120 days after birth only subtle effects were found in both 
open-field behavior and motor-coordination function when compared with control rats. 
Exposure of rats and rabbits to the reactive metabolite, styrene oxide, at 100 ppm throughout 
gestation resulted in reproductive and developmental toxicity, as well as maternal toxicity (Sikov 
et al., 1986). 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  5.1 ppm (21,000 m mg/m³) 
Study  Stewart et al., 1968
 
Study population  three human volunteers
 
Exposure method  inhalation
 
Critical effects  eye and throat irritation
 
LOAEL  99 ppm (for 20 minutes)
 
NOAEL  51 ppm
 
Exposure duration  1 hour
 
Extrapolated 1 hour concentration  51 ppm
 
LOAEL uncertainty factor  1
 
Interspecies uncertainty factor  1
 
Intraspecies uncertainty factor  10
 
Cumulative uncertainty factor  10
 
Reference Exposure Level  5.1 ppm (21 mg/m³; 21,000 mg/m³)
 
Level Protective Against Severe Adverse Effects 
Human subjects exposed to 376 ppm styrene for 25 minutes developed significant decrements in 
coordination and manual dexterity as well as nausea and discomfort (Stewart et al., 1968).  These 
effects were not observed in subjects exposed to 216 ppm for 1 hour.  An uncertainty factor of 10 
was applied to the 1-hour NOAEL of 216 ppm to account for increased susceptibility of sensitive 
human individuals.  The resulting level protective against severe adverse effect is 22 ppm (91 
mg/m³) for a 1-hour exposure to styrene.  However, sensitized individuals may be unable to 
tolerate exposure to styrene at detectable levels (Moscato et al., 1987; Hayes et al., 1991). 
Therefore, these individuals may not be protected by the severe adverse effect level developed for 
styrene in this document. 
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Level Protective Against Life-threatening Effects 
Spencer et al. (1942) observed a NOAEL for lethality in rats and guinea pigs of approximately 
10,000 ppm for a 1-hour exposure.  This was consistent with the lack of mortality observed 
following exposure for 2- to 3-hours at 5,000 ppm.  The LOAEL for lethality was 10,000 ppm for 
a 3-hour exposure.  Although more recent lethality studies in rats exist (Lundberg et al. 1986), the 
Spencer et al. (1942) report was the only study that was known to include a post-exposure 
observation period (2-4 weeks) long enough to observe delayed mortality due to pulmonary 
injury.  The lethal hepatic effect observed in mice following exposure to styrene is inconsistent 
with that seen in humans for acute exposures via inhalation.  Therefore, a life-threatening level 
based on mouse exposure data does not appear to be appropriate.  Uncertainty factors of 10 each 
were applied to the NOAEL (10,000 ppm) to account for interspecies differences and increased 
susceptibility of sensitive human individuals.  The total uncertainty factor incorporated was 100, 
resulting in a level of 100 ppm (420 mg/m³) protective against life-threatening effects for a 1-hour 
exposure to styrene. 
NIOSH (1995) reports an IDLH of 700 ppm based on acute inhalation toxicity in human workers. 
There is no allowance made for sensitive individuals. 
VIII.  References 
(ATSDR) Agency for Toxic Substances and Disease Registry. Toxicological profile for styrene. 
Atlanta: ATSDR; 1992. 
Amoore JE, Hautala E. Odor as an aid to chemical safety: Odor thresholds compared with 
threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. J Appl 
Toxicol 1983;3(6):272-290. 
Bond JA. Review of the toxicology of styrene. CRC Crit Rev Toxicol 1989;19(3):227-249. 
Bonnet P, Raoult G, Gradiski D. Concentrations lethales 50 des principaux hydrocarbures 
aromatiques. [LC50s of common aromatic hydrocarbons.] Arch Mal Med Trav Secur Soc 
1979;40:805-10. 
Bonnet P, Morele Y,Raoult G, Zissu D, Gradiski D. Determination de la concentration lethale50 
des principaux hydrocarbures aromatiques chez le rat. [Determination of the LC50 of common 
aromatic hydrocarbons in th rat.] Arch Mal Med Trav Secur Soc 1982;43:261-5. 
Brown NA. Reproductive and developmental toxicity of styrene. Reprod Toxicol 1991;5:3-29. 
Carpenter CP, Shaffer CB, Weil CS, Smyth HF Jr. Studies on the inhalation of 1,3 butadiene; 
with a comparison of its narcotic effect with benzol, toluol, and styrene, and a note on the 
elimination of styrene by the human. J Ind Hyg Toxicol 1944;26:69-77. 
C - 302 - Styrene Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
Cerny S, Mraz J, Flek J, Tichy M. Effect of ethanol on the urinary excretion of mandelic and 
phenylglyoxylic acids after human exposure to styrene. Int Arch Occup Environ Health 
1990;62:243-247. 
Cherry N, Gautrin D. Neurotoxic effects of styrene: further evidence. Br J Ind Med 1990;47:29­
37. 
Daston GP, Overmann GJ, Taubeneck MW, Lehman-McKeeman LD, Rogers, JM, Keen CL. The 
role of metallothionein induction and altered zinc status in maternally mediated developmental 
toxicity: comparison of the effects of urethane and styrene in rats. Toxicol Appl Pharmacol 
1991;110:450-463. 
Dogra RKS, Khanna S, Srivastava SN, Shukla LJ, Shanker R.  Styrene-induced 
immunomodulation in mice. Int J Immunopharmacol 1989;11(5):577-586. 
Dolara P, Lodovici M, Salvadori M, Santoni G, Caderni G.  Enzyme induction in humans exposed 
to styrene. Ann Occup Hyg 1983;27(2):183-188. 
Edling C, Ekberg K. No acute behavioral effects of exposure to styrene: a safe level of exposure? 
Br J Ind Med 1985;42:301-304. 
Elovaara E, Vainio H, Aitio A. Pulmonary toxicity of inhaled styrene in acetone-, phenobarbital-
and 3-methylcholanthrene-treated rats. Arch Toxicol 1990;64:365-369. 
Fujita H, Koizumi A, Furusawa T, Ikeda M. Decreased erythrocyte d-aminolevulinate dehydratase 
activity after styrene exposure. Biochem Pharmacol 1987;36(5):711-716. 
Gamberale F, Hultengren M. Exposure to styrene II. Psychological functions. Work Environ 
Health 1974;11:86-93. 
Götell, P., Axelson, O., Lindelöf, B. 1972. Field studies on human styrene exposure. Work 
Environ Health 1972;9:76-83. 
Harkonen H, Lindstrom K, Seppalainen AM, Sisko A Hernberg S. Exposure-response 
relationship between styrene exposure and central nervous functions. Scand J Work Environ 
Health 1978;4:53-59. 
Hayes JP, Lambourn L, Hopkirk JAC, Durham SR, Newman Taylor AJ. Occupational asthma due 
to styrene. Thorax 1991;46:396-397. 
Hemminki K, Hesso A. Reaction products of styrene oxide with guanosine in aqueous media. 
Carcinogenesis 1984;5(5):601-607. 
C - 303 - Styrene Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
(IARC) International Agency for Research on Cancer. Monographs on the evaluation of the 
carcinogenic risk of chemicals to man. Some monomers, plastics and synthetic elastomers, and 
acrolein. Vol. 19. Geneva: World Health Organization; 1979. p. 231-274 
Jaeger RJ, Conolly RB, Murphy SD. Toxicity and biochemical changes in rats after inhalation 
exposure to 1,1-dichloroethylene, bromobenzene, styrene, acrylonitrile or 2-chlorobutadiene. 
Toxicol Appl Pharmacol 1974;29:81. 
Kishi R, Chen BQ, Katakura Y, Ikeda T, Miyake H. Effect of prenatal exposure to styrene on the 
neurobehavioral development, activity, motor coordination, and learning behavior of rats. 
Neurotoxicol Teratol 1995;17(2):121-130. 
Leibman KC, Ortiz E. Epoxide intermediates in microsomal oxidation of olefins to glycols. J 
Pharmacol Exp Ther 1970;173:242-246. 
Lindbohm M-L. Effects of styrene on the reproductive health of women: a review.  In: Sorsa M, 
Peltonen K, Vainio H, Hemminki K, editors. Butadiene and styrene: assessment of health hazards. 
IARC Scientific Publications No. 127. Lyon, France: International Agency for Research on 
Cancer; 1993. p. 163-169. 
Lorimer WV, Lilis R, Nicholson WJ, Anderson H, Fischbein A, Daum S, et al. Clinical studies of 
styrene workers: initial findings. Environ Health Perspect 1976;17:171-181. 
Lundberg I, Ekdahl M, Kronevi T, Lidums V, Lundberg S. Relative hepatotoxicity of some 
industrial solvents after intraperitoneal injection or inhalation exposure in rats. Environ Res 
1986;40:411-420. 
Mendrala AL, Langvardt PW, Nitschke KD, Quast JF, Nolan RJ.  In vitro kinetics of styrene and 
styrene oxide metabolism in rat, mouse, and human. Arch Toxicol 1993;67:18-27. 
Morgan DL, Mahler JF, Dill JA, Price HC Jr, O’Conner RW, Adkins B Jr. Styrene inhalation 
toxicity studies in mice. II. Sex differences in susceptibility of B6C3F1 mice. Fundam Appl 
Toxicol 1993a;21:317-325. 
Morgan DL, Mahler JF, Dill JA, Price HC Jr, O’Conner RW, Adkins B Jr.  Styrene inhalation 
toxicity studies in mice. III. Strain differences in susceptibility. Fundam Appl Toxicol 
1993b;21:326-333. 
Morgan DL, Mahler JF, Moorman MP, Wilson RE, Price HC Jr, Richards JH, O’Connor RW. 
Comparison of styrene hepatotoxicity in B6C3F1 and Swiss mice. Fundam Appl Toxicol 1995 
27(2):217-222. 
Moscato G, Biscaldi G, Cottica D, Pugliese F, Candura S, Candura F. Occupational asthma due 
to styrene: Two case reports. J Occup Med 1987;29(12):957-960. 
C - 304 - Styrene Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
Murray FJ, John JA, Balmer MF, Schwetz BA. Teratologic evaluation of styrene given to rats and 
rabbits by inhalation or by gavage. Toxicology 1978;11:335-343. 
Rappaport SM, Ting D, Jin Z, Yeowell-O’Connell K, Waidyanatha S, McDonald T.  Application 
of Raney Nickel to measure adducts of styrene oxide with hemoglobin and albumin. Chem Res 
Toxicol 1993;6:238-244. 
Sedivec V, Flek J, Mraz M. Urinary excretion of mandelic and phenylglyoxylic acids after human 
exposure to styrene vapor. J Hyg Epidemiol Microb Immunol 1984;28(3):241-255. 
Shugaev BB. Concentrations of hydrocarbons in tissues as a measure of toxicity. Arch Environ 
Health 1969;18:878-882. 
Sikov MR, Cannon WC, Carr DB, Miller RA. Niemeier RW, Hardin B D. Reproductive 
toxicology of inhaled styrene oxide in rats and rabbits. J Appl Toxicol 1986;6(3):155-164. 
Sjoborg S, Fregert S, Trulsson L. Contact allergy to styrene and related chemicals. Contact 
Dermatitis 1984;10:94-96. 
Spencer HC, Irish DD, Adams EM, Rowe VK. The response of laboratory animals to monomeric 
styrene. J Ind Hyg Toxicol 1942;24(10):295-301. 
Srivastava S, Seth PK, Srivastava SP. Effect of styrene administration on rat testis. Arch Toxicol 
1989;63:43-46. 
Stewart RD, Dodd HC, Baretta ED, Schaffer AW. Human exposure to styrene vapor. Arch 
Environ Health 1968;16:656-662. 
Sumner SJ, Fennell TR. Review of the metabolic fate of styrene. CRC Crit Rev Toxicol 
1994;24(S1):S11-S33. 
Sumner SC, Cattley RC, Asgharian B, Janszen DB, Fennell TR. Evaluation of the metabolism and 
hepatotoxicity of styrene in F344 rats, B6C3F1 mice, and CD-1 mice following single and 
repeated inhalation exposures. Chem Biol Interact 1997;106(1):47-65 
Union Carbide Corporation. 1957. [cited in: IARC, 1979.] 
Vainio H, Hietanen E. Styrene. In: Snyder R, editor. Ethel Browning’s toxicity and metabolism of 
industrial solvents. 2nd ed. Vol. I. Hydrocarbons. New York: Elsevier; 1987. p. 199-208. 
Wolf MA, Rowe VK, McCollister DD, Hollingsworth RL, Oyen F. Toxicological studies of 
certain alkylated benzenes and benzene. AMA Arch Ind Health 1956;14:387-398. 
C - 305 - Styrene      
 
 




   
 
Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 






Synonyms  CAS Registry 
Number 
(NH4)HSO4  115.12  ammonium bisulfate; 
ammonium hydrogen sulfate 
7803-63-6 
(NH4)2SO4  132.14  ammonium sulfate  7783-20-2 
Fe2(SO4)3  399.88  ferric sulfate  10028-22-5 
Na2SO4  142.06  sodium sulfate  7757-82-6 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  120 m mg/m³ 
Critical effect(s)  small changes in airway function tests,
 especially in asthmatics. 
Hazard Index target(s)  Respiratory System 
II.  Physical and Chemical Properties  (HSDB, 1994) 
Description	  white and grayish-white crystals as solids 
Density  (NH4)2SO4: 1.769 g/cm
3 @ 20°C 
(NH4)HSO4: 1.78 g/cm





Boiling point	  H2SO4: 315-388°C 








Flashpoint  not applicable 
Explosive limits  not applicable 
Solubility  soluble in water, insoluble in acetone,
 ethanol, and ether 
Odor threshold  sulfate particles are odorless 
Odor Description  not applicable 
Metabolites  SO4
2- conjugates 
III.  Major Uses or Sources 
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Sulfates, including sulfuric acid, are produced in ambient air through oxidation of the SO2 and 
SO3 formed from fuel combustion (CARB, 1976).  Atmospheric ammonia reacts with sulfuric acid 
to form the ammonium salts (NH4)2SO4 and (NH4)HSO4.  Sodium sulfate occurs near marine 
sources.  Sulfuric acid is a strong acid used as an intermediate for linear alkylbenzene sulfonation 
surfactants used in dyes.  It is used in petroleum refining; for the nitration of explosives; in the 
manufacture of nitrocellulose; in caprolactam manufacturing; and as a drying agent for chlorine 
and nitric acid. 
IV.  Acute Toxicity to Humans 
The hydrogen ion content of the acid sulfate exposure provides a stimulus for 
bronchoconstriction, especially in asthmatics (Balmes et al., 1989).  Consequently, sulfuric acid is 
the most potent of the sulfates in producing airway responses, followed by (NH4)HSO4 and 
(NH4)2SO4 (Schlesinger and Graham, 1992; Schlesinger et al., 1992; Schlesinger and Chen, 
1994).  A comparison of sulfate aerosols on carbachol-induced bronchoconstriction in healthy 
humans confirmed the above relative potencies (Utell et al., 1982).  This Appendix also contains 
an acute toxicity summary for sulfuric acid. 
Utell et al. (1983) found that exposure of asthmatics to 450 mg/m³ sulfates as H2SO4, but not 
(NH4)HSO4, for 16 minutes resulted in decreased airway conductance (SGaw).  In this study, 
exposure to 1,000 mg/m³ of either type of sulfate resulted in decreased SGaw and decreased 
forced expiratory volume in one second.  Utell et al. (1982) reported that in normal volunteers a 
single exposure of 0.45 mg/m³ for 4 hours resulted in increased bronchoconstriction 24 hours 
later. 
Concomitant exposures to other pollutants in industrial areas, including SO2, ozone, and metallic 
aerosols can add to or potentiate the irritancy of H2SO4 (Amdur, 1989).  This is of particular 
concern for asthmatic individuals, who may be more sensitive than non-asthmatics to the irritant 
effects of H2SO4. 
Amdur et al. (1952) demonstrated that the lowest exposure detected by odor, taste, or irritation 
was 1 mg/m³ H2SO4.  The same experiment showed that a 30% increase in airway resistance in 
healthy individuals occurred following a 15-minute exposure to 0.35 mg/m³ H2SO4.  Avol and 
associates (1979) found no significant effects on pulmonary function in groups of 6 normal or 
asthmatic volunteers exposed for 2 hours to 0.1 mg/m³ (NH4)2SO4, 85 mg/m³ (NH4)HSO4, or 
75 mg/m³ H2SO4.  In contrast, adolescent asthmatics exposed to 0.068 mg/m³ H2SO4 for 40 
minutes exhibited pulmonary changes as measured by a 6% decrease from pre-exposure control 
(Koenig et al., 1989).  Avol and associates (1990) were unable to reproduce this observation by 
Koenig et al. (1989) of statistically significant respiratory dysfunction in a group of young 
asthmatics exposed to H2SO4 aerosol at concentrations near 100 mg/m³ (30 min at rest and 10 min 
at moderate exercise). 
Normal and asthmatic subjects exposed for 2 hours to 0.075 mg/m³ ferric sulfate (0.055 mg/m³ 
SO4
2-) showed no significant decrements in pulmonary function tests when compared to average 
pre-exposure values (Kleinman et al., 1981). 
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Predisposing Conditions for Sulfate Toxicity 
Medical:  The young may be more sensitive than adults to lethal effects, based on 
guinea pig LC50 values (Amdur, 1952).  Some asthmatics are more 
sensitive to pulmonary irritation produced by exposure to sulfuric acid. 
Chemical:  Exposure to ozone may increase the irritant effects of sulfate exposure 
(Amdur, 1989). 
Other:  Factors increasing the irritancy of sulfates include (1) adding steam to 
sulfuric acid mist; (2) high humidity in general; (3) large particle size 
(> 10 µm) (Sim and Pattle, 1957); and (4) concomitant exposure to other 
pollutants from automobile exhaust (SO2, ozone, and metallic aerosols) 
(Amdur, 1989). 
V.	  Acute Toxicity to Laboratory Animals 
The LC50 value for H2SO4 in young guinea pigs is 18 mg/m³ and in adult guinea pigs 50 mg/m³ for 
an 8-hour exposure (Amdur, 1952).  The LC50 for H2SO4 in rats is 1,402 mg/m³ for a one-hour 
exposure (RTECS, 1993). 
Sulfuric acid was more potent than either ammonium bisulfate or ferric sulfate in slowing particle 
clearance from the lungs of rats following a single 4-hour exposure to 3.5 mg/m³ (Phalen et al., 
1980). 
Schlesinger et al. (1990) showed that daily one hour exposures for five days to 250 µg/m³ H2SO4 
caused a decrease in prostaglandins E2, F2a, and thromboxane B2 in lavage fluid from rabbit 
lungs.  Similarly, a single 3-hour exposure to 75 µg/m³ H2SO4 resulted in decreased superoxide 
production and tumor necrosis factor in stimulated alveolar macrophages in rabbits (Schlesinger et 
al., 1992).  A single 3-hr exposure (300 µg/m³) to guinea pigs to fine (0.3 µm) diameter and 
ultrafine (0.04 µm) diameter H2SO4 caused an increase in lactate dehydrogenase, b-glucuronidase, 
and total protein in lung lavage fluid (Chen et al. 1992).  Together, these results indicate localized 
compromises in macrophage function and development of airway responsiveness in the alveolar 
region of the lung. 
VI.	  Reproductive or Developmental Toxicity 
There are no studies that conclusively show reproductive or developmental toxicity linked to 
sulfate exposure. 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  120 m mg/m³ 
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Study  Utell et al. (1983) 
Study population  17 human asthmatics 
Exposure method  inhalation of 100, 450 or 1000 mg/m³ H2SO4 aerosol 
Critical effects  decrease in airway conductance 
LOAEL  1,000 mg/m³ sulfate as H2SO4 
NOAEL  450 mg/m³ sulfate 
Exposure duration  16 min 
Extrapolated 1 hour concentration  120 mg/m³ (C
n * T = K, where n =1) 
LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  1 
Cumulative uncertainty factor  1 
Reference Exposure Level  120 mg/m³ 
The 24-hour California ambient air standard for sulfates is 25 mg/m³.  From the supporting 
document (CARB Staff Report, May 4, 1976), this number was derived mainly from a study by 
Amdur et al. (1952) and five CHESS (Community Health and Surveillance System) studies (dated 
1972 and discussed by Shy et al., 1973 and USEPA, 1974).  According to the document, the 
CAAQS for sulfate of 25 mg/m³, 24-hour average, is approximately midway between a lower 
bound of 10 mg/m³ for 24 hours recommended from the CHESS data and the upper bound of 33 
mg/m³ for 24 hours extrapolated from industrial experience with sulfuric acid mist.  In Amdur’s 
study the human exposure was for 15 minutes and it is unclear how the number derived remained 
unchanged after extrapolation to the 24-hour average.  Due to this uncertainty, the CAAQS for 
sulfate did not appear appropriate for derivation of the 1-hour REL.  However, if the standard of 
25 mg/m³ for 24 hours is time extrapolated to 1 hour using C
n x t = K. where n=2, a one hour 
value of 120 mg/m³ is also obtained.  Thus the REL is 120 mg/m³. 
The 24-hour California ambient standard for particulate matter with a diameter at or below 10 
microns (PM10) is 50 mg/m³. 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database.  (NIOSH (1995) lists an IDLH 
of 15 mg/m³ for sulfuric acid.) 
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ACUTE TOXICITY SUMMARY 
SULFUR DIOXIDE 
(sulfur oxide; sulfurous anhydride; sulfurous oxide) 
CAS Registry Number: 7446-09-5 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  660 m mg/m³ 
Critical effect(s)  impairment of airway function, especially in 
asthmatics 
Hazard Index target(s)  Respiratory system 
II.  Physical and Chemical Properties (from HSDB, 1994 except as noted) 
Description  colorless gas 
Molecular formula  SO2 
Molecular weight  64.1 
Density  2.62 g/L @ 25°C 
Boiling point  -10°C 
Melting point  -72.7°C 
Vapor pressure  2432 mm Hg @ 20°C 
Flashpoint  unknown 
Explosive limits  unknown 
Solubility  soluble in water, ethanol, chloroform, ether,
 acetic acid 
Odor threshold  0.62 - 1.2 ppm (Ryazanov, 1961) 
Odor description  pungent, irritating odor 
Metabolites  sulfate (SO4 
2-) salts 
Conversion factor  1 ppm = 2.62 mg/m³ @ 25°C 
III.  Major Uses or Sources 
Sulfur dioxide is a product of combustion from coal and other fuel burning.  In addition, there are 
many natural sources of atmospheric SO2, including volcanoes and marine and terrestrial biogenic 
emissions (CARB, 1983).  The decay of biologic materials containing sulfur results in the release 
of reduced sulfur compounds which are oxidized to SO2 and other sulfur oxides (CARB, 1983). 
Anthropogenic sources of sulfur dioxide in ambient air include oil refineries, power plants and 
automobiles. 
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IV.  Acute Toxicity to Humans 
A thorough review of the scientific and epidemiological literature regarding the acute toxicity of 
sulfur dioxide (SO2) to animals and humans can be found in the Recommendation for the one-
hour Ambient Air Quality Standard for sulfur dioxide (OEHHA, 1994).  Several of the most 
sensitive studies considered in the development of the California Ambient Air Quality Standard 
(CARB, 1983) for SO2 are described below. 
Increased airway resistance (SRaw) in asthmatics following exposure to SO2 has been frequently 
reported.  Horstman et al. (1986) exposed 27 adults with mild asthma to 0, 0.25, 0.5, 1.0, and 
2.0 ppm (0, 0.66, 1.31, 2.62, and 5.24 mg/m³) SO2 for 10 minutes of moderate exercise.  The 
exposure concentrations required for a 100% increase in SRaw varied considerably in the study 
group, from less than 0.5 ppm (1.31 mg/m³) to greater than 2.0 ppm (5.24 mg/m³).  The median 
concentration to which these subjects responded with a 100% increase in SRaw was 0.75 ppm 
(1.97 mg/m³). 
Linn et al. (1983) reported that moderate to severe asthmatics with a ventilation rate of 
approximately 48 L/minute exhibited increased SRaw of 120% when exposed to 0.4 ppm 
(1.05 mg/m³) SO2 for 5 minutes. 
A study on the acute effects of SO2 on SRaw was conducted by Linn et al. (1987).  Included in 
this study were mild, moderate, and severe asthmatics, atopic individuals, and normal subjects. 
These subjects were exposed to 0, 0.2, 0.4, or 0.6 ppm (0, 0.52, 1.05, or 2.1 mg/m³) SO2 for 1 
hour.  Analysis of the Linn data by OEHHA scientists showed that statistically significant 
increases in SRaw and respiratory symptoms were present in atopic individuals exposed to 
0.6 ppm for 15-55 minutes, and in moderate to severe asthmatic individuals at 0.4 ppm after 55 
minutes.  Mild asthmatics were the only group that showed a significant increase in SRaw and 
respiratory symptoms at 0.2 ppm.  OEHHA staff also analyzed data from the most sensitive 30 
percent of the subjects studied by Linn et al. (1987), and found that asthmatics, atopics, and 
normal subjects all exhibited statistically significantly increased SRaw after exposure to 0.2 ppm. 
However, at this concentration, the changes in SRaw were not considered clinically significant, 
since they were not accompanied by respiratory symptoms.  Of these groups, asthmatics were the 
most sensitive to the effects of SO2 on SRaw. 
Male volunteers with mild asthma were exposed to 0.0, 0.25, 0.5, or 1.0 ppm SO2 for 75 minutes 
(Roger et al., 1985).  Each exposure included three 10 minute moderate treadmill exercise 
periods.  Specific airway resistance was not significantly increased after exercise with 0.25 ppm 
SO2 compared to clean air exposure, but was significantly increased with 0.5 and 1.0 ppm SO2. 
A study by Bethel et al. (1985) showed that asthmatics exposed for 15 minutes to 0.25 ppm SO2 
had significantly increased SRaw.  However, exposure in this study was via mouthpiece and may 
have resulted in a greater dose than similar concentrations in chamber exposures.  Furthermore, 
the results of Bethel et al. could not be reproduced at higher exposures and workloads. 
Fourteen healthy non-smokers (7 men and 7 women), between 20 and 46 years old, were exposed 
for 30 minutes to filtered air while free breathing and to 2.0 ppm SO2 with either free breathing, 
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forced oral, or forced nasal breathing with continuous exercise (Bedi and Horvath, 1989).  Lack 
of changes in pulmonary function tests including airway resistance indicated that 2.0 ppm SO2 did 
not adversely affect normal subjects. 
Predisposing Conditions for Sulfur Dioxide Toxicity 
Medical:  Asthmatics are more sensitive to the irritant effects of SO2 than non-
asthmatics, especially when exercising or when in cold, dry air (Koenig et 
al., 1982; Bethel et al., 1984).  Some allergic or atopic individuals and 
people with Reactive Airways Disease Syndrome (RADS; acute, irritant-
induced asthma) may also be more sensitive to SO2 irritation (Linn et al., 
1987). 
Chemical:  Co-exposures to other irritants such as sulfuric acid, nitrogen dioxide, and 
ozone may potentiate the irritant effects of SO2 on pulmonary function in 
asthmatics (OEHHA, 1994).  In animals, co-exposure to ozone has been 
shown to increase the irritancy of SO2 and to increase airway 
responsiveness (Amdur et al., 1978). 
V.  Acute Toxicity to Laboratory Animals 
Due to the abundance of clinical data collected using human asthmatics, animal data were not 
used as the basis for the 1-hour Ambient Air Quality Standard for SO2. 
VI.  Reproductive or Developmental Toxicity 
Reports of reproductive effects in the human workplace have involved mixed exposures, and are 
not definitive.  Some data in rats indicate that SO2 affects the estrous cycle, increases the 
incidence of fetal resorptions, and impairs fetal development at concentrations as low as 4.97 
mg/m³ (Reprotext, 1993). 
VII.  Derivation of Acute Toxicity Exposure Levels (for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):   660 µg/m³ 
Study  multiple studies as cited in OEHHA, 1994 
Study population  multiple studies of healthy, asthmatic and 
atopic volunteers 
Exposure method  controlled inhalation exposures with or 
without exercise 
Critical effects  adverse respiratory effects, bronchoconstriction 
LOAEL  0.4 ppm for 5 minutes (Linn et al., 1983) 
0.4 ppm for 60 minutes (Linn et al., 1987) 
0.5 ppm for 75 minutes (Roger et al., 1985) 
NOAEL  0.25 ppm for 75 minutes (Roger et al., 1985) 
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0.2 ppm for 60 minutes (Linn et al., 1987) 
Exposure duration  varied 
Equivalent 1 hour concentration  0.25 ppm (consensus value from multiple studies) 
LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  1 
Cumulative uncertainty factor  1 
Reference Exposure Level  0.25 ppm (250 ppb; 0.66 mg/m³; 660 µg/m³)
  (California Ambient Air Quality Standard) 
After reviewing several studies on controlled human data on acute exposures of normal, 
asthmatic, and atopic individuals to low concentrations of SO2 (0.25 - 2.0 ppm), OEHHA staff 
concluded that exposure to 0.25 ppm, the California Ambient Air Quality Standard (CAAQS) for 
SO2, would not result in discomforting respiratory effects in sensitive individuals for a period of 1­
hour.  The CAAQS for SO2 aims to protect sensitive individuals (i.e., exercising asthmatics) from 
lower respiratory effects of acute exposure.  The procedures used to derive the CAAQS were not 
identical to those in this report.  However, based on a thorough review of the literature, OEHHA 
staff concluded that an exposure concentration of 0.25 ppm SO2 for 1 hour is comparable to a 
NOAEL in sensitive individuals.  This level is felt to protect asthmatic individuals because adverse 
effects are consistently observed only at higher concentrations under conditions of moderate 
exercise (ventilation rates of > 40 L/minute) and there is an inconsistency in response to SO2 
exposure at lower concentrations. 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
Asthmatics exposed via a mouthpiece to 5 ppm SO2 for 10 minutes required bronchodilator 
therapy because of bronchoconstriction resulting from the exposure (Sheppard et al., 1980).  The 
Sheppard et al. (1980) study was a mouthpiece study, and therefore most likely resulted in a 
greater inhaled dose of SO2 than in chamber studies.  The AIHA (1992) developed an ERPG-2 of 
3 ppm (7.86 mg/m³) and stated that exposures above 3 ppm are likely to cause 
bronchoconstriction of varying severity in a significant portion of the population.  This could 
impair the ability to take protective action.  There is therefore no margin of safety included for 
protection of these individuals from severe effects, a serious shortcoming. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
Many reports show that asthmatics exposed to SO2 at low concentrations (0.37-5 ppm) exhibit 
bronchoconstriction (Amdur, 1974; Bell et al., 1977; Bethel et al., 1983, 1984; Koenig et al., 
1980, 1982; Linn et al., 1977, 1983, 1984; Sheppard et al., 1980, 1981).  In its selection of an 
ERPG-3 for SO2 of 15 ppm (39.3 mg/m³), the AIHA (1992) acknowledges that the 
bronchoconstriction observed in asthmatics could be potentially life-threatening, but does not 
C - 315 - Sulfur Dioxide Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
include specific information about the adoption of the 15 ppm value.  The ERPG-3 is based on 
estimation of lethality in asthmatics exposed to SO2 for 1-hour.  Although the ERPG document 
correctly considers asthmatics as a sensitive subpopulation for this level, the specific rationale 
used to develop a margin of safety for the ERPG-3 is not presented, a serious shortcoming. 
NIOSH (1995) lists an IDLH for sulfur dioxide of 100 ppm.  It is based on the statement by 
AIHA (1955) that 50 to 100 ppm is considered the maximum concentration for exposures of 0.5 
to 1 hour (Henderson and Haggard, 1943). 
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ACUTE TOXICOLOGY SUMMARY 





Synonyms  CAS Registry 
Number 
H2SO4  98.1  sulfuric acid; dithionic acid; 
pyrosulphuric acid 
7664-93-9 
SO3  80.07  sulfur trioxide  7446-71-9 
H2SO4 + SO3  Oleum  8014-95-7 
I.  Acute Toxicity Exposure Levels (for a 1-hour exposure) 
Inhalation reference exposure level  120 m mg/m³ 
Critical effect(s)  small changes in airway function tests, 
especially in asthmatics 
Hazard Index target(s)  Respiratory System 
II.  Physical and Chemical Properties  (HSDB, 1994) 
Description  colorless liquid
 
Molecular formula  H2SO4 (sulfuric acid)
 
H2SO4 + SO3 (oleum)
 
Molecular weight  98.1 (sulfuric acid)
 




3 @ 15°C (oleum)
 
Boiling point  315-388°C
 
Melting point  10.4°C
 
Vapor pressure  0.001 mm Hg @ 20°C
 
Solubility  soluble in water
 





Conversion factor  1 ppm = 4.08 mg/m³
 
Description of oleum 
Oleum is supersaturated anhydrous H2SO4 with varying concentrations of free sulfur trioxide 
(SO3).  Upon contact with atmospheric moisture, SO3 is rapidly converted to H2SO4 mist. 
Exposure to sulfur trioxide is, therefore, equivalent to exposure to H2SO4. 
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III.  Major Uses or Sources 
Sulfuric acid is a strong acid used as an intermediate for linear alkylbenzene sulfonation 
surfactants used in dyes; in petroleum refining; for the nitration of explosives; in the manufacture 
of nitrocellulose; in caprolactam manufacturing; and as a drying agent for chlorine and nitric acid. 
IV.  Acute Toxicity to Humans 
The irritant properties of H2SO4 account for its acute as well as its chronic effects.  Two 
properties of concentrated H2SO4, its acidity and its hygroscopic potential, make it particularly 
corrosive as compared to diluted H2SO4 to the skin, eyes and respiratory tract.  In splash accidents 
involving H2SO4, the heat, liberated by dilution of the concentrated acid with water, can add 
thermal burn to the chemical injury caused by the acid itself.  Sulfuric acid exposure results in 
irritation of the tracheobronchial tree, which leads to bronchoconstriction and altered lung 
function. Sim and Pattle (1957) reported that in healthy volunteers a range of exposures, from 2.9 
to 39 mg/m³, resulted in coughing, bronchoconstriction, and rales.  In this study, H2SO4 mists of 
20.8 mg/m³ were nearly intolerable to the volunteers exposed for 30 minutes. Wet mists were also 
more potent inducers of irritation than dry mists at the same exposure levels. 
Delayed effects of sulfuric acid exposure may be seen in some individuals.  Utell et al. (1983) 
reported that in normal volunteers a single exposure to 0.45 mg/m³ for 4 hours resulted in 
increased bronchoconstriction 24 hours later.  Concomitant exposures to other pollutants in 
industrial areas, including SO2, ozone, and metallic aerosols, can add to, or potentiate the irritancy 
of H2SO4 (Amdur, 1989).  This is of particular concern for asthmatic individuals, who may be 
more sensitive than non-asthmatics to the irritant effects of H2SO4.  In human asthmatic subjects, 
exposure to 450 µg/m³ sulfuric acid for 16 minutes decreased airway conductance but the 
magnitude of the decrease was not clinically significant (Utell et al., 1984). 
Dental erosion has been reported in battery plant workers exposed chronically to sulfuric acid mist 
at 0.8 mg/m³ for several months (Malcolm and Paul, 1961).  Dose-dependent dental erosion has 
also been described in workers exposed to an average concentration of 0.23 mg/m³ for at least 4 
months (Gamble et al., 1984). 
A report of acute respiratory distress syndrome (ARDS) in a 23 year-old worker exposed to 
unknown high concentrations of sulfuric acid for over 30 minutes showed parenchymal opacities 
on roentgenogram and deficits in lung function that resolved within 6 weeks of treatment (Knapp 
et al., 1991). 
Predisposing Conditions for Sulfuric Acid Toxicity 
Medical:  The young may be more sensitive than adults to the lethal effects based on guinea 
pig LC50 values (Amdur, 1952a).  Asthmatics are more sensitive to the pulmonary 
irritation produced by exposure to sulfuric acid. 
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Chemical:  Factors increasing the irritancy of sulfuric acid include: 1) adding steam to sulfuric 
acid mist; 2) high humidity in general; 3) large particle size (> 10 microns) (Sim 
and Pattle, 1957); and 4) concomitant exposure to other pollutants from 
automobile exhaust (SO2, ozone, and metallic aerosols) (Amdur, 1989). 
V. 	 Acute Toxicity in Laboratory Animals 
The LC50 in young guinea pigs is 18 mg/m³ and in old guinea pigs is 50 mg/m³ for an 8-hour 
exposure (Amdur 1952a).  The LC50 in rats is 1,402 mg/m³ for a one-hour exposure (RTECS, 
1994). 
Schlesinger et al. (1990) showed that daily one hour exposures for five days to 250 µg/m³ H2SO4 
caused a decrease in prostaglandins E2, F2a, and thromboxane B2 in lavage fluid from rabbit lungs. 
Donkeys exposed to 102-106 µg/m³ H2SO4 for 1 hr/day, 5 days/wk, over 6 months developed 
significant impairment of normal bronchial clearance, with sustained effects for up to 3 months 
after cessation of treatment (Schlesinger et al., 1978).  Exposure of monkeys to 2.43 -4.79 mg/m³ 
sulfuric acid for 78 weeks resulted in adverse histological changes in lung parenchymal tissue.  In 
addition, decreased blood oxygenation was observed (Alarie et al., 1973). 
Five squirrel monkeys exposed to 2.6 mg/m³ sulfuric acid for 1 hour exhibited significant (11%) 
increases in total respiratory system resistance compared with 5 sham-exposed monkeys, although 
no overt clinical signs of coughing, wheezing, or blinking were observed (Kleinman and Hackney, 
1978). 
VI. 	 Reproductive or Developmental Toxicity 
There are no confirmed studies that conclusively show reproductive or developmental toxicity 
linked to sulfuric acid exposure. 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  120 m mg/m³ (30 ppb) 
Study  Utell et al., 1984 
Study population  17 human asthmatics 
Exposure method  inhalation 
Critical effects  small changes in airway function, especially in 
asthmatics 
LOAEL  1,000 µg/m³ 
NOAEL  450 µg/m³ (112 ppb) 
Exposure duration  16 minutes 
Extrapolated 1 hour concentration  120 mg/m³  (C
1 * 1 hr = 450
1 mg/m³ * 16/60 hr) 
LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
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Intraspecies uncertainty factor  1 
Cumulative uncertainty factor  1 
Reference Exposure Level  120 mg/m³ (30 ppb) 
The lowest observed effect level (considered a NOAEL) for a 16-minute exposure resulting in 
decreased airway conductance in human asthmatic subjects was 450 µg/m³ (112 ppb) sulfuric 
acid.  The REL of 120 mg/m³ for a 1-hour exposure was derived using the formula C
n * T = K, 
where n = 1.  The 24-hour California ambient air standard for sulfates is 25 mg/m³, and the 24­
hour California ambient standard for particulate matter with a diameter at or below 10 microns 
(PM10) is 50 mg/m³. 
Level Protective Against Severe Adverse Effects 
The National Research Council (NRC, 1986) derived a 60-minute EEGL (Emergency Exposure 
Guidance Level) of 1 mg/m³ for sulfuric acid.  Exposure of humans to 5 mg/m³ H2SO4 for 15 
minutes was tolerable to the subjects.  Monkeys, exposed to 4.8 mg/m³ continuously over a 78 
week period, showed some respiratory changes.  Similar changes were seen in this study at a 
concentration of 2.4 mg/m³, but were not included by NAS in the EEGL document.  Adjusting 
these results for time of exposure yielded an acceptable human exposure of 1 mg/m³ for 60 
minutes.  The AIHA (1989) ERPG-2 level of 10 mg/m³ does not consider LC50 data in guinea 
pigs of 18 mg/m³ (Amdur et al, 1952a).  Furthermore, the ERPG document relies heavily on older 
studies that are either unpublished or poorly presented (Sim and Pattle, 1957).  Thus, although the 
EEGL 60-minute value of 1 mg/m³ did not include respiratory changes in monkeys exposed to 2.4 
mg/m³, this value is health protective based on a thorough review of the literature. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
Exposure of healthy, human subjects for 30 minutes to 20.8 mg/m³ H2SO4 was almost intolerable, 
causing coughing, bronchoconstriction and rales.  LC50 values in young guinea pigs are reported 
to be 18 mg/m³, and 50 mg/m³ for older guinea pigs (Amdur et al., 1952a).  Based on these 
results, the AIHA has set an ERPG-3 value for a 1 hour exposure of 30 mg/m³ as protective 
against the lethal effects of H2SO4.  The ERPG-3 value may be inappropriately high based on the 
guinea pig 8-hour LC50 values (Amdur et al., 1952a).  Silbaugh et al. (1981) also reported 22% 
mortality of guinea pigs exposed to 24.3 mg/m³ H2SO4 for 35 minutes.  Consequently, this level 
cannot be recommended as the level protective against life-threatening effects. 
NIOSH (1995) lists a revised IDLH for sulfuric acid of 15 mg/m³ based on acute inhalation 
toxicity data in humans (Amdur et al. 1952b) and animals (Amdur et al. 1952a; Treon et al. 
1950).  NIOSH states: “This may be a conservative value due to the lack of relevant acute toxicity 
data for  workers exposed to concentrations above 5 mg/m³.”  This value would also not take into 
account sensitive human subpopulations. 
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ACUTE TOXICITY SUMMARY 
TOLUENE 
(methyl benzene, methyl benzol, phenyl methane, toluol) 
CAS Registry Number: 108-88-3 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  37,000 m mg/m³ 
Critical effect(s)  headache, dizziness, slight eye and nose irritation 
Hazard Index target(s)  Nervous System; Eyes; Respiratory System;
 Reproductive/developmental 
II.  Physical and Chemical Properties (HSDB, 1993 except as noted) 
Description  colorless liquid 
Molecular formula  C7H8 
Molecular weight  92.13 
Density  0.861 g/cm
3 @ 25ºC (Low et al, 1988) 
Boiling point  111ºC 
Melting point  -95ºC 
Vapor pressure  28.1 mm Hg @ 25ºC (USEPA, 1984) 
Flashpoint  4º C, closed cup 
Explosive limits  upper = 7% 
lower = 1.27% 
Solubility  miscible in organic solvents 
Odor threshold  1.6 ppm (geometric mean) (AIHA, 1989) 
Odor description  sour, burnt (AIHA, 1989) 
Metabolites  hippuric acid 
Conversion factor  1 ppm = 3.75 mg/m³ @ 25ºC 
III.  Major Uses or Sources 
Toluene occurs naturally as a component of crude oil and is produced in petroleum refining and 
coke oven operations.  It is used in household aerosols, nail polish, paints and paint thinners, 
lacquers, rust inhibitors, adhesives, and solvent based cleaning agents.  Toluene is also used in 
printing operations, leather tanning, and chemical processes.  Benzene and other polycyclic 
aromatic hydrocarbons (PAHs) are common contaminants of toluene.  Toluene is considered a 
sentinel chemical for benzene exposure. 
IV.  Acute Toxicity to Humans 
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Dysfunction of the central nervous system and narcosis are the major effects of acute exposure to 
toluene (ATSDR, 1989).  Irritation of the skin, eye, and respiratory tract can also result. 
Inhalational abuse of toluene with high level exposure for long periods of time has produced 
progressive and irreversible changes in brain structure and function (Spencer and Schaumberg, 
1985). 
Two separate workplace incidents involving acute inhalation exposure to toluene in several 
workers resulted in effects of euphoria, drunkenness, dizziness, nausea, confusion, incoordination, 
drowsiness, and loss of consciousness (Longley et al., 1967).  The toluene concentrations were 
estimated at 10,000 to 30,000 ppm (40,000 to 110,000 mg/m³) although no actual measurements 
were made.  No long-term follow-up of the exposed workers was conducted. 
Reaction time and perceptual speed were studied in 12 young male subjects exposed by inhalation 
to toluene concentrations ranging from 100 to 700 ppm (400 to 3,000 mg/m³), each for a 20­
minute interval (Gamberale and Hultengren, 1972).  Statistically significant impaired reaction time 
was apparent following exposure to 300 ppm (1,000 mg/m³) toluene.  A statistically significant 
impairment in perceptual speed was observed at 700 ppm toluene.  No effects were observed at 
100 ppm. 
Two groups of middle aged workers, one with previous occupational exposure to solvents and 
one without, were exposed once to 100 ppm (400 mg/m³) of toluene for 6.5 hours (Baelum et al., 
1985).  Fatigue, sleepiness, a feeling of intoxication, and eye, nose and throat irritation were 
reported.  Decrements in manual dexterity, color discrimination, and accuracy in visual perception 
were also observed.  Greater sensitivity to toluene was noted for those subjects with previous 
solvent exposure. 
Nasal mucus flow, lung function, psychometric performance, and subjective responses were 
studied in 16 young healthy males exposed to toluene concentrations ranging from 10 to 100 ppm 
(40 mg/m³ to 400 mg/m³) for 6 hours (Andersen et al, 1983).  Headaches, dizziness, a feeling of 
intoxication, and slight eye and upper respiratory irritation were reported at 100 ppm.  The 
subjects also reported that it became more difficult to participate in the battery of psychometric 
tests and that their reaction time felt impaired at 100 ppm.  No significant objective changes 
compared to control exposures were observed in the performance test results.  No symptoms 
were reported at 10 and 40 ppm. 
A battery of neurobehavioral and performance tests was conducted among 42 young men and 
women exposed by inhalation for 7 hours to 0, 75, and 150 ppm (0, 280, and 560 mg/m³) toluene 
(Echeverria et al., 1989).  Statistically significant decrements in visual short term memory, visual 
perception, and psychomotor skills were observed at 150 ppm compared to control exposures.  A 
dose-dependent increase in subjective symptoms of headache and eye irritation was also observed. 
Wilson (1943) reported that workers exposed to concentrations of commercial toluene ranging 
from 50 to 200 ppm (200 to 750 mg/m³) for periods of 1 to 3 weeks experienced headaches, 
lassitude, and loss of appetite.  At 200 to 500 ppm (750 to 2,000 mg/m³), symptoms of nausea, 
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bad taste in the mouth, slightly impaired coordination and reaction time, and temporary memory 
loss were also observed.  Exposure to 500 to 1,500 ppm (2,000 to 5,600 mg/m³) resulted in 
palpitations, extreme weakness, pronounced loss of coordination, and impaired reaction time. 
Red blood cell counts were decreased and there were 2 cases of aplastic anemia.  The 
hematologic effects were most likely caused by benzene impurities (ACGIH, 1986). 
Three volunteer subjects exposed by inhalation to toluene concentrations ranging from 50 to 100 
ppm (200 to 400 mg/m³), 8 hours per day, 2 times per week over 8 weeks experienced fatigue, 
drowsiness, and headaches (von Oettingen et al., 1942).  At 200 to 800 ppm (750 to 3,000 
mg/m³), symptoms of muscular weakness, confusion, impaired coordination, paresthesia, and 
nausea were also reported.  After exposure to 800 ppm, all 3 subjects reported considerable after­
effects (severe nervousness, muscular fatigue, and insomnia) lasting several days. 
Predisposing Conditions for Toluene Toxicity 
Medical:  Since toluene is metabolized by the liver, persons with liver disease may be 
sensitive to its acute effects (ATSDR, 1993).  Persons with preexisting neurologic 
or heart disease may also be at increased risk for adverse effects resulting from 
exposure to toluene (Reprotext, 1999). 
Chemical:  Because salicylates and alcohol competitively inhibit toluene metabolism, 
concurrent use of these substances may increase susceptibility to toluene toxicity 
(ATSDR, 1993).  Persons using over-the-counter bronchial dilators containing 
epinephrine might be more sensitive to arrhythmogenic effects (Reprotext, 1999). 
V.  Acute Toxicity to Laboratory Animals 
The 1-hour LC50 for toluene in the rat is 26,700 ppm (100,000 mg/m³) (Pryor et al, 1978).  The 
6-hour LC50s in rats and mice are 4,618 ppm (17,320 mg/m³) and 6,949 ppm (26,060 mg/m³), 
respectively (Bonnet et al., 1982).  The 8-hour LC50 is 5,300 ppm (19,900 mg/m³) in the mouse 
(Svirbely et al, 1943). 
Attention deficits and impairment of visual-motor abilities were observed in 6 macaque monkeys 
exposed by inhalation for 50 minutes to 2,000-4,500 ppm (7,500-17,000 mg/m³) toluene (Taylor 
and Evans, 1985).  Expired carbon dioxide increased in a dose-dependent manner from 100 to 
3,000 ppm (400 to 11,000 mg/m³).  The investigators stated that changes in expired carbon 
dioxide may provide evidence of combined behavioral, respiratory, sensory, and metabolic effects. 
Dose-dependent decreases in behavioral performance and central nervous system depression were 
observed in mice and rats exposed by inhalation to toluene at concentrations ranging from 2,600 
to 12,000 ppm (9,800 to 45,000 mg/m³) for up to 3 hours (Bruckner and Peterson, 1981). 
Younger animals were more susceptible to toluene toxicity and mice were more sensitive than rats 
of the same age. 
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Kishi et al. (1988) used the shock avoidance response test to study behavioral effects in rats. 
Inhalation exposure to 125 ppm (469 mg/m³) toluene for 20 minutes resulted in a considerable 
decrease in the effective avoidance response rate. 
Hearing loss was observed in rats after exposure to 1,000 ppm (4,000 mg/m³) toluene, 14 hours 
per day for 2 weeks (Pryor et al., 1984). 
VI.  Reproductive or Developmental Effects 
Toluene is listed under the California Proposition 65 (Cal/EPA, Safe Drinking Water and Toxic 
Enforcement Act of 1986) as a developmental toxicant.  Most of the information concerning the 
adverse developmental effects of toluene in humans comes from case reports among children of 
deliberate toluene “sniffers.”  Children whose mothers had inhaled large quantities of toluene 
during pregnancy were found to have microencephaly, facial and limb abnormalities, attention 
deficits, hyperactivity, developmental delay with greater language impairment, and growth 
retardation (Hersch et al., 1985; Hersch, 1989).  Multiple solvent and/or other substance abuse 
may have contributed to the observed abnormalities.  Growth retardation, craniofacial 
abnormalities, and hyperchloremic acidosis were observed in the children of women with severe 
renal tubular acidosis induced by chronic paint sniffing (Goodwin, 1988).  Preterm delivery, 
perinatal death, and growth retardation were significantly increased among 21 newborns exposed 
to toluene as a result of maternal inhalation abuse (Wilkins-Haug and Gabow, 1991).  A case-
referent study of women occupationally exposed to organic solvents, including toluene, reported 
increased incidences of urogenital, gastrointestinal, and cardiac anomalies in their children 
(McDonald et al., 1987).  Although toluene was considered to be the most likely teratogenic 
agent, concurrent exposures to other developmental toxicants make this conclusion difficult to 
support. 
There are several animal studies of varying quality on the reproductive and developmental toxicity 
of toluene.  A complete review of the developmental toxicology of toluene is available (Donald et 
al., 1991).  Selected studies are summarized below. 
Shigeta et al. (1982) reported statistically significant increases in the number of fetal resorptions 
observed in the offspring of mice exposed by inhalation to 100 ppm (400 mg/m³) toluene for 6 
hours per day on days 1-17 of gestation.  Exposure at 1,000 ppm (4,000 mg/m³) resulted in a 
statistically significant increase in the incidence of extra ribs. 
A statistically insignificant increased incidence of extra ribs was observed in rats exposed by 
inhalation to 1,000 mg/m³ toluene for 24 hours per day on days 7-14 of gestation (Tatrai et al., 
1980).  Fused sternebrae and extra ribs were observed in rats exposed to 400 ppm (1,500 mg/m³
) 
toluene for 24 hours per day on days 9-14 of gestation (Hudak and Ungvary, 1978).  Skeletal 
retardation was observed in rats exposed to 266 ppm (1,000 mg/m³) toluene for 8 hours per day 
on days 1-21 of gestation and to 400 ppm (1,500 mg/m³) 24 hours per day on days 1-8.  This 
same group exposed mice to 400 ppm (1,500 mg/m³) or to 133 ppm (500 mg/m³) toluene for 24 
hours per day on days 6-13 of gestation.  All dams died at the higher dose and a statistically 
significant decrease in fetal weight was observed at the lower dose. 
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Skeletal retardations were observed in the offspring of pregnant rabbits exposed by inhalation to 
concentrations of toluene ranging from 30 to 300 ppm (100 to 1,000 mg/m³), 6 hours per day on 
days 6-18 of gestation (Klimisch et al., 1992).  These results were not dose-dependent and were 
not reproduced in two additional groups of rabbits exposed to 100 and 500 ppm (400 and 2,000 
mg/m³) toluene. 
A statistically significant increase in the number of animals showing a 13/13 rib profile (which is 
considered normal) was observed in mice exposed to 400 ppm (1,500 mg/m³) toluene, 7 hours per 
day on days 7-16 of gestation (Courtney et al., 1986).  An increased number of resorptions was 
observed in mice exposed to 400 ppm toluene on days 6-15 of gestation (Gleich and Hofman, 
1983); the daily exposure duration was not specified. 
These preceding animal studies support the association between toluene exposure and effects on 
somatic development of the fetus.  However, the value of these studies is limited by issues such as 
unknown or unconventional exposure durations, inadequate descriptions of maternal toxicity, use 
of individual offspring instead of litters for statistical analyses, and purity of toluene used (Donald 
et al., 1991). 
The best available study relating toluene exposure and retardation of somatic development is one 
in which adult rats of 2 generations were exposed for 6 hours per day to 0, 100, 500 or 
2,000 ppm (0, 375, 1,875, or 7,500 mg/m³) toluene during an 80-day premating period and a 15 
day mating period (IRDC, 1985).  Adult females of both generations were also exposed on days 
1-20 of gestation and on days 5-21 of lactation.  The mean body weights of fetuses of both 
generations of dams exposed to 2,000 ppm were significantly decreased compared to controls. 
No maternal toxicity was reported.  Exposure at this level to the male parent only did not result in 
any adverse effects.  The NOAEL for fetotoxic effects in this study was 500 ppm. 
In a recent teratogenicity study by inhalation, Ono et al. (1995) exposed pregnant Sprague-
Dawley rats to 600 or 2000 ppm toluene for 6 h/day from day 7 to day 17 of pregnancy.  The 
control group inhaled “conditioned” clean air.  Maternal exposure to 2000 ppm caused significant 
toxic effects such as body weight suppression in dams and offspring, high fetal mortality, and 
embryonic growth retardation.  However, no external, internal, or skeletal anomalies were 
observed in the fetuses of any treated group.  In addition, there were no differences in the results 
of pre- and post-weaning behavioral tests of the offspring.  No changes which could be related to 
toluene were apparent in the 600 ppm group.  Thus 600 ppm is a NOAEL is this study. 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects): 9.8 ppm (37,000 m mg/m³) 
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Study  Andersen et al., 1983 
Study population  16 young, healthy males 
Exposure method  inhalation 
Critical effects  impaired reaction time and symptoms of headache,
 dizziness, a feeling of intoxication and slight eye
 and nose irritation 
LOAEL  100 ppm 
NOAEL  40 ppm 
Exposure duration  6 hours 
Extrapolated 1 hour concentration  98 ppm (40
2ppm* 6 h = C
2 * 1 h )
  (see Table 12 for information on “n”) 
LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  10 
Reference Exposure Level  9.8 ppm (37 mg/m³; 37,000 mg/m³) 
Level Protective Against Severe Adverse Effects 
In a 2-generation study, adult rats were exposed for 6 hours per day to 0, 100, 500, or 2,000 ppm 
(0, 375, 1875, or 7,500 mg/m³) toluene during an 80-day premating period and a 15 day mating 
period (International Research and Development Corporation, 1985).  Adult females of both 
generations were also exposed on days 1-20 of gestation and on days 5-21 of lactation.  The mean 
body weights of fetuses of both generations of dams exposed to 2,000 ppm were significantly 
decreased compared to controls.  No maternal toxicity was reported.  The NOAEL for fetotoxic 
effects in this study was 500 ppm.  The NOAEL reported in the study, a chronic exposure study, 
was in the same concentration range as the LOAELs reported in other acute exposure studies 
addressing reproductive and developmental toxicity, summarized above.  However, because the 
IRDC study was judged to be methodologically the most sound of all the studies considered for 
this endpoint (Donald et al., 1991), it was chosen as the basis for the severe adverse effect level. 
An uncertainty factor of 100 was applied to the NOAEL to account for animal to human 
extrapolation and for intraindividual variability.  The 6-hour exposure serves as the basis for the 
level protective against severe adverse effects.  This yields a 6-hour level protective against severe 
adverse effects of 5 ppm (19 mg/m³). 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
NIOSH (1995) reports an IDLH for toluene of 500 ppm.  According to NIOSH, “It has been 
reported that extreme fatigue, mental confusion, exhilaration, nausea, headache and dizziness 
resulted from exposures to 600 ppm by the end of 3 hours [von Oettingen et al. 1942].  In 
addition, the following observations have been made: some workers will tolerate concentrations 
ranging up to 200 ppm for 6 to 8 hours daily with no demonstrable ill effects; 200 to 500 ppm for 
6 to 8 hours will cause tiredness and lassitude in most workers; and concentrations over 500 ppm 
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for 1 to 3 hours are definitely dangerous and will cause symptoms attributable to depression of the 
central nervous system and the bone marrow [Wilson 1943].  It has also been reported that 
exposure to concentrations greater than 4,000 ppm for more than 5 minutes might limit self 
rescue ability [ANSI 1973].  After 20 minutes, exposures to concentrations at 300, 500, or 700 
ppm resulted in significant increases in reaction times; a significant decrease in perceptual speed 
resulted after a 20­minute exposure to 700 ppm [Gamberale and Hultengren 1972]. .... The 
revised IDLH for toluene is 500 ppm based on acute inhalation toxicity data in humans 
[Gamberale and Hultengren 1972; von Oettingen et al. 1942; Wilson 1943].”  Based on its 
documentation, the IDLH of 500 ppm, designed for a 30 minute exposure, does not appear to be 
low enough to protect the general public, especially sensitive individuals, from life-threatening 
effects for 1 hour.  Therefore, no recommendation for a level protective against life-threatening 
effects is made at this time. 
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ACUTE TOXICITY SUMMARY 
TRIETHYLAMINE 
(diethylaminoethane; ethanamine; N,N-diethylethanamine) 
CAS Registry Number: 121-44-8 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  2,800 m mg/m³ 
Critical effect(s)  visual disturbances and ocular irritation in 
healthy human volunteers 
Hazard Index target(s)  Nervous System; Eyes 
II.  Physical and Chemical Properties  (Nelson and Bull, 1990) 
Description  colorless liquid 
Molecular formula  C6H15N 
Molecular weight  101.9 
Density  0.726 g/cm
3 @ 25°C 
Boiling point  89.3°C 
Melting point  -115°C 
Vapor pressure  400 mm Hg @ 31.5°C 
Flashpoint  -6.7°C 
Explosive limits  unknown 
Solubility  soluble in water above 18.7°C; very soluble in
 acetone, benzene and chloroform 
Odor threshold  0.36 - 1.12 mg/m³ 
Odor description  fishy odor 
Metabolites  acetaldehyde, ammonia and urea 
Conversion factor  1 ppm = 4.14 mg/m³ @ 25°C 
III.  Major Uses or Sources 
Triethylamine (TEA) is primarily used as a cross-linking catalyst in the production of 
polyurethane foam used in the manufacture of cores for metal castings (Albrecht and Stephenson, 
1988).  Triethylamine is also used as a catalyst for epoxy resins, and as a corrosion inhibitor for 
polymers (Nelson and Bull, 1990). 
IV.  Acute Toxicity to Humans 
Vapors of TEA may cause irritation of the mucous membranes resulting in lacrimation, 
conjunctivitis, corneal edema, cough and respiratory distress (Albrecht and Stephenson, 1988). 
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Headache, nausea, and faintness may also be observed following TEA exposure (Albrecht and 
Stephenson, 1988). 
Two volunteers exposed to 4.35 ppm (18 mg/m³) TEA for 8 hours, experienced visual 
disturbances (hazy vision and halo perception); corneal edema was observed in these individuals 
(Akesson et al., 1985).  The ocular effects were transient, and resolved within hours of the 
exposure.  Similar symptoms were reported by workers exposed over an 11-week period to 2.90 
ppm (12-13 mg/m³) TEA (Akesson et al., 1986).  However, eye examinations performed in these 
workers were normal, without signs of corneal edema. 
Predisposing Conditions for Triethylamine Toxicity 
Medical:  Unknown 
Chemical:  Unknown 
V.	  Acute Toxicity to Laboratory Animals 
Lethality studies in several animal species are relatively consistent: (1) exposure to 1,000 ppm for 
4 hours was lethal to 1 of 3 guinea pigs (Carpenter et al., 1948), (2) exposure to 1,425 ppm for 2 
hours was lethal to an unspecified percentage of mice (Izmerov et al., 1982); and (3) exposure to 
1,000 ppm for 4 hours was lethal to 1 of 6 rats (Smyth et al., 1951).  The acute oral LD50 is 460 
and 546 mg TEA/kg in rats and mice, respectively (RTECS, 1993). 
No significant gross or histological changes were observed in male and female rats exposed for 
6 hours/day, 5 days/week for 28 weeks to TEA concentrations up to 247 ppm (1,023 mg/m³) 
(Lynch et al., 1990).  However, degeneration of heart muscle, hepatocellular necrosis, and 
pulmonary edema were observed in rabbits following exposure to 100 ppm (414 mg/m³) TEA for 
7 hours/day, 5 days/week, for 6 weeks (Brieger and Hodes, 1951).  Exposure of rabbits to 
50 ppm (207 mg/m³) TEA for 5 days/week for 6 weeks caused corneal edema and erosions. 
Pulmonary irritation in these rabbits was evidenced by peribronchial lymphocyte infiltration and 
slight hepatic parenchymal degeneration. 
VI.	  Reproductive or Developmental Toxicity 
Triethylamine is highly teratogenic to chick embryos.  The ED50 for embryotoxicity and 
unspecified external malformations is 0.9 µmol/egg (Korhonen et al., 1983). 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  2,800 µg/m³ 
Study  Akesson et al., 1985; Akesson et al., 1988 
Study population  two healthy human volunteers 
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Exposure method  8 hour exposures to 10 or 20 mg/m³ TEA 
Critical effects  visual disturbances, eye irritation, and 
transient corneal edema 
LOAEL  20 mg/m³ 
NOAEL  10 mg/m³ 
Exposure duration  8 hours 
Equivalent 1 hour concentration  28 mg/m³ (C
2 * 1 hr = [10 mg/m³]
2 * 8 hrs) 
LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  10 
Reference Exposure Level  2.8 mg/m³ (2,800 µg/m³; 0.68 ppm; 680 ppb) 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
NIOSH (1995) has developed a 30-minute IDLH value of 200 ppm (830 mg/m³).  The value is 
based on three animal lethality studies: (1) a 4 hour LC33 of 1,000 ppm for guinea pigs (Carpenter 
et al., 1948), (2) a 2 hour LClo of 1,425 ppm for mice (Izmerov et al., 1982); and (3) a 4 hour 
LC33 of 1,000 ppm for rats (Smyth et al., 1951).  Using duration extrapolation to 30 minutes and 
a ten-fold uncertainty factor, the three data sets yielded values of 200 to 228 ppm. 
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ACUTE TOXICITY SUMMARY 
VANADIUM PENTOXIDE 
(divanadium pentoxide, vanadic anhydride, vanadium oxide) 
CAS Registry Number: 1314-62-1 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  30 m mg/m³ 
Critical effect(s)  coughing, increased mucus production 
in healthy human volunteers 
Hazard Index target(s)  Respiratory System; Eyes 
II.  Physical and Chemical Properties  (HSDB, 1994 except as noted) 
Description  yellow to rust-brown solid (ACGIH, 1986) 
Molecular formula  V2O5 
Molecular weight  181.88 g/mol 
Density  3.357 g/cm
3 @ 18°C 
Boiling point  1750°C 
Melting point  690°C 
Vapor pressure  not applicable 
Flashpoint  not applicable 
Explosive limits  not applicable 
Solubility  soluble in acetone, concentrated acid and alkali;
 slightly soluble in water; insoluble in alcohol 
Odor threshold  not applicable 
Metabolites  none reported (Friberg et al., 1986) 
Conversion factor  not applicable 
III.  Major Uses or Sources 
Vanadium pentoxide (V2O5) is used as a catalyst in oxidation reactions in the production of 
sulfuric acid and plastics (Friberg et al., 1986).  It is also used as a mordant in dyeing, and as a 
component of photographic developer (Sax, 1984).  In the manufacture of glass, it is used as a 
depolarizer and inhibitor of UV light. V2O5 is also released by the combustion of fossil fuels which 
contain small amounts of vanadium (NAS, 1974). 
IV.  Acute Toxicity to Humans 
Inhalation of V2O5 fumes, released during the production of V2O5  and during boiler cleaning, 
may result in irritation of the eyes and respiratory tract and in bronchospasm (Friberg et al., 
1986).  The onset of symptoms occurs 1-6 days after exposure.  Subsequent exposures to V2O5 
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may result in increased severity of symptoms, most likely a result of sensitization (Zenz et al., 
1962).  The eye irritation threshold is reported to be 0.5 mg/m³ (Reprotext, 1994).  The 
respiratory irritation threshold is reported to be below that of ocular irritation (Grant, 1986). 
High level acute exposures may result in CNS effects including paralysis, respiratory depression, 
convulsions, and death (Reprotext, 1994). 
Zenz and Berg (1967) studied human sensory responses to controlled vanadium pentoxide 
exposures in 9 male volunteers.  The men were exposed for one 8 hour period to 1.0, 0.25 or 0.1 
mg/m
3 of V2O5.  The 2 volunteers exposed to 1.0 mg/m
3 began to cough during the latter half of 
the exposure.  The coughing persisted for 8 days after exposure.  Five subjects were exposed to 
0.25 mg/m
3.  On the morning following their exposure, all five unexpectedly developed a loose,
 
productive cough which lasted 7 to 10 days.  The 2 volunteers exposed to 0.1 mg/m
3 V2O5
 
showed no symptoms during or immediately after exposure but within 24 hours they formed
 
considerable mucus which subsided after 4 days.
 
Workers exposed to 0.1-0.3 mg/m³ V2O5 for a minimum of 6 months reported symptoms of eye,
 
nose, and throat irritation and exhibited signs of pharyngeal infection, green tongue and wheezing
 
or rales (Lewis, 1959).
 
Predisposing Conditions for Vanadium Pentoxide Toxicity 
Medical:  Persons with preexisting skin, eye, kidney, or respiratory conditions, especially 
chronic bronchitis or asthma, or other underlying cardiopulmonary disease may be 
more sensitive to the toxic effects of V2O5 (Reprotext, 1999). 
Chemical:  Persons exposed simultaneously to phthalic anhydride and V2O5 may be at greater 
risk for exacerbation of asthma.  Persons exposed to other vanadium compounds 
may be more sensitive to the effects of V2O5 exposure (Reprotext, 1999). 
V.  Acute Toxicity to Laboratory Animals 
Exposure to V2O5 at a concentration of 500 mg/m³ for 23 minutes was found to be lethal in cats 
(Heimberger, 1929).  Gastroenteritis, pneumonitis, and pulmonary edema were observed at 
autopsy.  An LCLO of 205 mg/m³ V2O5 for a 7-hour exposure was reported for rabbits (Sjoberg, 
1950).  Autopsy results revealed marked tracheitis, bronchopneumonia, and pulmonary edema.  In 
this same study, rabbits exposed to 20-40 mg/m³ V2O5 for 1 hour per day for “several months” 
(exact duration not specified) exhibited chronic rhinitis and tracheitis, emphysema and patches of 
lung atelectasis with bronchopneumonia. 
Sixteen adult, male cynomolgus monkeys were acutely exposed by whole-body inhalation of V2O5 
dust (0.5 mg or 5.0 mg/m³) at 1 week intervals (Knecht et al., 1985).  Pulmonary function tests 
were performed one day after each inhalation exposure, and inflammation was studied by 
cytologic analysis of lower respiratory tract cells by bronchoalveolar lavage (BAL).  Pre-exposure 
comparisons were used in place of controls.  Reduction in air-flow in central and peripheral 
airways was noted without any change in parenchymal function.  V2O5 dust exposures led to a 
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significant increase in the total cell counts recovered from the lungs by BAL, including very large 
increases in absolute number and relative percentage of polymorphonuclear leukocytes (PMN). 
Rats (200-250 g) were intratracheally administered vanadium compounds or vehicle (as a control) 
(Pierce et al., 1996).  The soluble vanadium compounds NaVO3 and VOSO4 induced rapid and 
intense  pulmonary inflammation and inflammatory cytokine mRNA expression while the less 
soluble V2O5 was much less potent.  Significant neutrophil influx was noted 24 hours after V2O5 
exposure and persisted for several days.  Analysis of lavage fluid, BAL cells, and lung suggested 
rapid clearance of the V2O5 from the lung surface and accumulation in BAL cells and lung tissue. 
VI. 	 Reproductive or Developmental Toxicity 
No studies of reproductive toxicity in humans were available (Reprotext, 1994). 
Pregnant mice injected with a total dose of 28 mg V2O5 (delivered as 0.15 ml of a 1.0 mM V2O5 
solution) on the eighth day of gestation exhibited a significant increase in number of fetuses with 
delayed skeletal ossification as compared to controls (Wide, 1984).  Additionally, six of the 
exposed fetuses had “broken spinal cords”. 
Pregnant Wistar rats were administered V2O5 by intraperitoneal injections on days 6-15 
(3 mg/kg/day) or 9-12 (5 mg/kg/day) of gestation (Zhang et al., 1993a). Single doses  (5 
mg/kg/day) were also given on days 9, 10, or 11.  Decreased maternal weight gain was noted. 
Effects observed included decreased weight gain, increased fetal mortality, decreased fetal weight, 
delayed bone ossification, subcutaneous hemorrhage, and dilation of lateral ventricles and renal 
pelvis.  The greatest effects were noted from exposures on day 10. In a second study, pregnant 
Wistar rats were administered 0.33, 1, or 3 mg/kg-day over days 6-15 of gestation (Zhang et al., 
1993b). Adverse effects similar to that reported in the companion paper (Zhang et al., 1993a) 
were noted in the two higher dose groups but not in the low dose group. 
Effects of vanadium pentoxide treatment on male mouse reproductive function were investigated 
(Altamirano-Lozano et al., 1996).  Sperm count, motility, and morphology were adversely 
affected, and decreased fertility rate was reported after intraperitoneal injection of 8.5 mg V2O5 
per kg body weight. 
VII. 	 Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  30 µg/m³ 
Study  Zenz and Berg, 1967 
Study population  nine healthy human volunteers 
Exposure method  8 hour exposures to 0.1, 0.25 or 1.0 mg/m³ V2O5 
Critical effects  subjective reports of increased respiratory mucus 
production that was cleared by coughing. 
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LOAEL  0.25 mg/m³ V2O5 (n = 5)  NOAEL/LOEL 
0.1 mg/m³ V2O5 (n = 2) 
Exposure duration  8 hours 
Equivalent 1 hour concentration  0.3 mg/m³ (C
2 * 1 hr = [0.1 mg/m³]
2 * 8 hrs) 
LOAEL uncertainty factor  1 (effect observed was not adverse) 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  10 
Reference Exposure Level  0.03 mg/m³ (30 µg/m³) 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
A NIOSH-IDLH of 35 mg/m³ has been presented, but the method for deriving this value was not 
reported (NIOSH, 1995). 
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ACUTE TOXICITY SUMMARY 
VINYL CHLORIDE 
(chloroethene; chloroethylene; vinyl chloride monomer; VC; VCM) 
CAS Registry Number: 75-01-4 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  180,000 m mg/m³ 
Critical effect(s)  mild headache and dryness of eyes and nose 
in healthy human volunteers 
Hazard Index target(s)  Eyes; Nervous System; Respiratory System 
II.  Physical and Chemical Properties  (HSDB, 1994 except as noted) 
Description  colorless gas 
Molecular formula  C2H3Cl 
Molecular weight  62.5 
Density  2.56 g/L @ 25°C 
Boiling point  -13°C 
Melting point  -153.8°C 
Vapor pressure  2,660 mm Hg @ 25°C 
Flashpoint  -77.8°C (open cup) (ACGIH, 1991) 
Explosive limits  4 to 22% by volume in air (ACGIH, 1991) 
Solubility  soluble in alcohol, ethyl ether, carbon 
tetrachloride, benzene 
Odor threshold  3,000 ppm (Amoore and Hautala, 1983) 
Odor description  sweet (AIHA, 1989) 
Metabolites  chloroethylene oxide, chloroacetic acid
 (Antweiler, 1976)
 
Conversion factor  1 ppm = 2.56 mg/m³ @ 25°C
 
III.  Major Uses or Sources 
The chief use of vinyl chloride (VC) is in the production of polyvinyl chloride (PVC) resins used 
for plastic piping and conduit (IARC, 1979).  It is also used in the manufacture of methyl 
chloroform.  Vinyl chloride was used as a propellant until 1974 when this use was banned due to 
its demonstrated carcinogenicity.  The main toxicological concern for vinyl chloride is from 
exposure to the monomer rather than the polymerized forms (i.e., PVC).  Thermal decomposition 
of VC produces hydrogen chloride, carbon monoxide, and traces of phosgene (ACGIH, 1991). 
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IV.  Acute Toxicity to Humans 
The primary acute physiological effect of VC inhalation is CNS depression (Holmberg, 1984). 
Anesthesia may occur at high concentrations (7,000 - 10,000 ppm) for short durations in both 
animals and humans (Purchase et al., 1987). 
In two accidental human poisonings, workers became incapacitated when exposed to high 
concentrations of VC gas (Anon., 1953).  Following removal from exposure, one of the workers 
experienced tightness of the chest, nausea, abdominal pain, and headache.  Before VC’s 
relationship with certain forms of cancer was established, workers in at least one polyvinyl 
chloride manufacturing facility reportedly inhaled VC fumes for its euphoric effect, sometimes to 
the point of unconsciousness (Klein, 1976).  Danziger (1960) reported a worker death associated 
with exposure to high concentrations of VC.  Autopsy revealed cyanosis, local burns of the 
conjunctiva and cornea, congestion of internal organs (especially lung and kidneys), and failure of 
blood to clot. 
Suciu et al. (1975) reported that factory workers exposed to high concentrations of VC 
experienced euphoria, giddiness, somnolence and, in some cases, narcosis.  Yearly average 
concentrations reported at this factory were between 98 and 2,298 mg/m³ (38 to 898 ppm). 
Two male volunteers exposed to 25,000 ppm (64,000 mg/m³) VC for 3 minutes reported the odor 
as pleasant, but became dizzy and disoriented to the space and size of surrounding objects.  The 
men also reported a burning sensation on the soles of their feet (Patty et al., 1930). 
In a controlled exposure, 6 adult volunteers (3 male, 3 female) were exposed to varying 
concentrations up to 20,000 ppm (51,200 mg/m³) of VC via an oral-nasal mask (Lester et al., 
1963).  The 5 minute exposures took place twice each day and were separated by 6-hour periods 
for 3 successive days.  No CNS effects were reported at 4,000 ppm (10,240 mg/m³).  Exposure to 
12,000 ppm (30,720 mg/m³) resulted in complaints of dizziness and reeling in 2 subjects.  A clear 
dose-response was observed in this study, but statistical comparisons were not made by the 
authors. 
In a chamber exposure, human volunteers were exposed to 59, 261, 491, or 493 ppm VC for up 
to 7.5 hours (excluding a 0.5-hour lunch period) (Baretta et al., 1969).  The subjects exposed to 
either 59 or 261 ppm VC reported no untoward effects.  However, 2 of 7 subjects exposed to 491 
ppm for 3.5 hours and 2 of 4 subjects exposed to 493 ppm for 7.5 hours reported mild headache 
and dryness of eyes and nose. 
Vinyl chloride is known to cause “vinyl chloride disease” upon repeated exposures in workers. 
This multisystem disorder consists of Raynaud’s phenomenon, acro-osteolysis, thrombocytopenia, 
splenomegaly, portal fibrosis, and hepatic and pulmonary dysfunction (IARC, 1979).  This disease 
is likely an immune complex disorder from the adsorption of VC or a metabolite onto tissue 
proteins and is unlikely to occur following single acute exposure (Ward et al., 1976). 
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Differences in genetic susceptibility to hepatotoxicity of vinyl chloride have been described 
(Huang et al., 1997).  Vinyl chloride is metabolized by cytochrome P450 2E1 (CYP2E1) to form 
the toxic electrophilic metabolites, chloroethylene oxide and chloroacetaldehyde.  These 
metabolites are detoxified by glutathione S-transferases (GSTs).  A total of 251 workers from 
polyvinyl chloride plants were categorized into high or low exposure groups based on air 
exposure monitoring.  Serum alanine aminotransferase (ALT) was used as an indicator of liver 
function.  CYP2E1, GST theta, and GST mu were determined by polymerase chain reaction 
(PCR) and restriction fragment length polymorphism (RFLP) on peripheral white blood cell DNA. 
For the low vinyl chloride exposure group, positive GST theta (odds ratio = 3.8, 95% CI 1.2­
14.5) but not CYP2E1 was associated with abnormal ALT levels in serum.  For the high exposure 
group, a c2c2 CYP2E1 genotype was associated with an increased risk of abnormal ALT (odds 
ratio = 5.4, 95% CI 0.7-35.1), while a positive GST theta was associated with significantly 
reduced risk of abnormal ALT (odds ratio = 0.3, 95% CI 0.1-0.9). 
Predisposing Conditions for Vinyl Chloride Toxicity 
Medical:  Inherited cytochrome P450 and glutathione S-transferase alleles may affect 
individual susceptibility (Huang et al., 1997). 
Chemical:  Inducers of hepatic cytochrome-P450 enzymes, such as phenobarbital, potentiate 
the hepatotoxic effects of inhaled VC in rats (IARC, 1979; Jaeger et al., 1974; 
Kappus et al., 1975).  Liver damage was measured by the release of alanine alpha­
ketoglutarate, SGOT, and SGPT enzymes. 
Ethanol co-administration with VC resulted in greater toxicity to pregnant mice, 
rats, or rabbits than exposure to VC alone (John et al., 1981). 
V.  Acute Toxicity to Laboratory Animals 
A lethality study was carried out by Prodan et al. (1975) in which mice, rats, guinea pigs, and 
rabbits were exposed to VC for 2 hours.  Deaths were due to respiratory failure.  Animals that 
were still alive at the end of exposure recovered quickly following removal from the gas. 
However, no post-exposure observation period was included in the study to investigate possible 
delayed mortality.  Table 1 below shows the LC50, MLE05 (maximum likelihood estimate expected 
to produce a response rate of 5%), BC05 and BC01 (benchmark concentration at the 95% lower 
confidence interval of the 5% and 1% lethality level, respectively) as determined by log normal 
probit analysis (Crump, 1984; Crump and Howe, 1983). 
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Table 1. 	 Animal lethality benchmark concentration estimates from Prodan et al. (1975) 
for 2-hour vinyl chloride exposure 












mouse  299  253  246  227 
rat
1  (394)  (329)  (292)  (260) 
guinea pig  591  527  453  410 
rabbit  600  545  466  424 
1  Log normal probit analysis indicates the data points for rats resulted in an unacceptable fit. 
Exposure of rats, mice and guinea pigs to 100,000 ppm VC (5 animals/species) resulted in 
increased motor activity at 10 minutes but progressed to muscular incoordination, unsteady gait 
and pronounced tremor in all species 15 minutes into the exposure (Mastromatteo et al., 1960). 
Rats and mice became unconscious at 25 minutes while guinea pigs remained conscious during 
the entire 30 minute exposure period.  At 200,000 and 300,000 ppm VC, rats and mice exhibited 
muscular incoordination at 2 and 1 minutes, respectively, following initiation of exposure.  Guinea 
pigs were slightly more tolerant of the CNS depressant effects at these concentrations. Deaths in 
mice, rats and guinea pigs occurred at 200,000 ppm and above, 300,000 ppm and 400,000 ppm, 
respectively. 
Exposure to 5,000 and 10,000 ppm vinyl chloride for 8 hours did not produce signs of CNS 
depression in guinea pigs (Patty et al., 1930).  Inhalation of 25,000 ppm (64,000 mg/m³) (sample 
size unspecified) resulted in motor ataxia and unsteadiness by 5 minutes, deep narcosis without 
convulsions or twitching by 90 minutes, and death by respiratory paralysis by 6 hours.  Gross 
pathological changes included congestion and edema in the lungs, and hyperemia in the liver and 
kidneys.  Guinea pigs exposed to 100,000 ppm developed complete loss of coordination and 
incomplete narcosis 2 minutes into exposure. 
Lester et al. (1963) showed that rats exposed to 50,000 ppm (128,000 mg/m³) VC for 2 hours 
exhibited moderate intoxication with loss of the righting reflex.  Loss of the corneal reflex was 
apparent following a 2-hour exposure to 100,000 ppm (256,000 mg/m³).  Exposure of these rats 
to 100,000 ppm (256,000 mg/m³) for two 8-hour periods resulted in mortality from a “pneumonic 
process.” 
Tatrai and Ungvary (1981) exposed mice, rats and rabbits to 1,500 ppm VC for up to 24 hours. 
Rats and rabbits were unaffected, but 90% of mice died following 12 hours of exposure and 100% 
of mice died following 24 hours of exposure.  Pathological examination of mice revealed 
hemorrhages and vasodilatation in the lungs, suggestive of pulmonary edema. 
Dermal exposure of monkeys to gaseous VC indicated that absorption of VC across the intact 
skin is very limited (Hefner et al., 1975). 
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Rhesus monkeys eliminate VC at approximately half the rate of mice and rats (Buchter et al., 
1980).  Rodents may therefore be less sensitive than primates to systemic VC toxicity. 
VI. 	 Reproductive or Developmental Toxicity 
In a review of the epidemiological data, Hemminki and Vineis (1985) concluded that there was 
inadequate evidence of increased teratogenesis in humans exposed to VC. 
Animal studies have also failed to show significant association between VC exposure and 
teratogenesis.  In rats, exposure to VC at a concentration of 1,500 ppm (3,840 mg/m³) for 24 
hours/day during all three trimesters of pregnancy did not result in an increased incidence of birth 
defects (13-28 rats per group) (Ungvary et al., 1978).  Pharmacokinetic studies showed that VC 
crossed the placental barrier of these rats, and was present in fetal blood. 
John et al. (1981) showed that exposure of pregnant mice, rats or rabbits to 500 ppm (1,280 
mg/m³) VC for 7 hours/day during organogenesis did not result in teratogenicity or 
embryotoxicity.  Inhalation of 2,500 ppm (6,400 mg/m³) caused slight ossification changes in the 
offspring and maternal mortality in the mice.  Co-administration of 15% ethanol in drinking water 
resulted in maternal toxicity, but no elevation in fetal effects above that seen for ethanol exposure 
alone. 
Male mice exposed to 30,000 ppm (76,800 mg/m³) VC 6 hours/day for 5 days were mated to 
control females, with no resultant increase in spontaneous abortions (Purchase, 1975).  However, 
Bi et al. (1985) showed that inhalation exposure of male rats to 100 ppm VC for 6 hours/day, 6 
days/week for 3 months resulted in significant damage to seminiferous tubules compared to 
controls  (p < 0.05). 
VII. 	 Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 
Reference Exposure Level (protective against mild adverse effects):  180,000 m mg/m³ 
Study  Baretta et al., 1969 
Study population  4-8 healthy human volunteers 
Exposure method  (1) 7.5 hour exposures to 261 ppm VC 
(2) 3.5 hour exposures to 491 ppm VC 
(3) 7.5 hour exposures to 493 ppm VC 
Critical effects	  subjective reports of mild headaches and 
dryness of eyes and nose (groups 2 and 3); 
no effects reported by group 1 
LOAEL  3.5 to 7.5 hour exposure to 491 or 493 ppm 
NOAEL  7.5 hour exposure to 261 ppm 
Exposure duration  7.5 hours 
Equivalent 1 hour concentration  715 ppm (C
2 * 1 hr = [261 ppm]
2* 7.5 hrs) 
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LOAEL uncertainty factor  1 
Interspecies uncertainty factor  1 
Intraspecies uncertainty factor  10 
Cumulative uncertainty factor  10 
Reference Exposure Level  72 ppm (180 mg/m³, 180,000 mg/m³) 
Level Protective Against Severe Adverse Effects 
Exposure of guinea pigs to 10,000 ppm VC for 8 hours did not produce signs of CNS depression 
(Patty et al., 1930).  Exposure to 25,000 ppm produced motor ataxia and unsteadiness within 5 
minutes and unconsciousness in 90 minutes.  Exposure to 100,000 ppm produced motor ataxia 
within 2 minutes in guinea pigs (Patty et al., 1930) and motor ataxia with a pronounced tremor 
within 15 minutes in rats and mice (Mastromatteo et al., 1960).  Higher concentrations of VC 
(200,000 and 300,000 ppm) reduced the onset of CNS depression to 1 to 2 minutes following 
initiation of exposure (Mastromatteo et al., 1960). 
Based on the results of Patty et al. (1930), the NOAEL for motor ataxia, or muscular 
incoordination, in guinea pigs was 10,000 ppm for 8-hour exposure.  The LOAEL was 25,000 
ppm, which resulted in motor ataxia within 5 minutes and unconsciousness in 90 minutes.  The 
NOAEL was adjusted to a 1-hour exposure by the formula C
n x T = K (where “n” = 2), which 
resulted in a concentration of 28,282 ppm VC.  Applying uncertainty factors of 10 each to 
account for interspecies differences and increased susceptibility of sensitive human individuals 
results in a final value of 280 ppm (720 mg/m³) VC for a level protective against serious adverse 
effects. 
Level Protective Against Life-threatening Effects 
Log-normal analysis of lethality data for mice, guinea pigs, and rabbits (Prodan et al., 1975) 
yielded BC05 estimates of 246,000, 453,000, and 466,000 mg/m³, respectively.  Mastromatteo et 
al. (1960) reported 30-minute no-observed-lethality levels of 100,000, 300,000, and 400,000 
ppm, respectively, for mice, rats and guinea pigs. 
The study by Prodan et al. (1975) provides data from which to derive an estimate for VC using 
the benchmark concentration approach.  The BC05 of the most sensitive species, the mouse, was 
adjusted to a 1-hour equivalent exposure using the equation C
n x T = K, where “n” = 2. 
Uncertainty factors of 3 and 10 were applied to the adjusted BC05 of 348,000 mg/m³ (136,000 
ppm) to account for interspecies differences and increased susceptibility of sensitive human 
individuals, respectively.  The resultant level protective against life-threatening effects is thus 
4,500 ppm (12,000 mg/m³). 
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ACUTE TOXICITY SUMMARY 
XYLENES 
(technical xylene (o-, m-, p-), xylol)

 (o-xylene, ortho-xylene, 1,2-dimethylbenzene, 2-xylene)
 
(m-xylene, meta-xylene, 1,3-dimethylbenzene, 3-xylene)
 
(p-xylene, para-xylene, 1,4-dimethylbenzene, 4-xylene)
 
CAS Registry Numbers: 1330-20-7 (technical), 95-47-6 (o-), 108-38-3 (m-), 106-42-3 (p-) 
I.  Acute Toxicity Summary (for a 1-hour exposure) 
Inhalation reference exposure level  22,000 m mg/m³ 
Critical effect(s)  eye irritation in healthy human volunteers 
Hazard Index target(s)  Eyes; Respiratory System 
II.  Physical and Chemical Properties  (HSDB, 1994 except as noted) 
Description  colorless liquid 
Molecular formula  C8H10 
Molecular weight  106.2 
Density  0.881 g/cm
3 (o-); 0.860 (m-); 0.861 (p-) @ 20°C 
Boiling point  144.4°C (o-); 139.1°C (m-); 138.4°C (p-) 
Melting point  -25°C (o-); -47.87°C (m-); 13.3°C (p-) 
Vapor pressure  6.6 (o-); 8.39 (m-); 8.87 (p-) mm Hg at 25°C 
Flashpoint  17.2°C (o-); 25°C (m-); 25°C (p-) (closed cup) 
Explosive limits  unknown 
Solubility  insoluble in water; soluble in ethanol, acetone, ether 
Odor threshold  1 ppm (Carpenter et al., 1975) 
Metabolites  methylbenzoic acids 
Conversion factor  1 ppm = 4.34 mg/m³ @ 25°C 
III.  Major Uses or Sources 
As nonexplosive aromatic hydrocarbons, mixtures of the three (technical xylene) isomers are 
heavily used in the chemical industry and in the petroleum industry as a solvent and gasoline 
“antiknock” additives.  Of the three isomers, p-xylene is produced in the highest quantities in the 
U.S. for use in the synthesis of terephthalic acid for polymer fibers such as mylar and dacron 
(HSDB, 1994).  However, m-xylene is the most abundant isomer in the environment (Silverman 
and Schatz, 1991). 
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IV.  Acute Toxicity to Humans 
Despite its structural similarity to benzene, xylene does not influence hematopoiesis.  The 
principal systemic effects of acute xylene exposure are on the central nervous system (CNS) but it 
is also a respiratory and eye irritant.  Nelson et al. (1943) exposed 10 healthy human volunteers 
for periods of 3 to 5 minutes to estimated concentrations of 100 or 200 ppm technical grade 
xylene.  The subjects reported eye, nose, and throat irritation at 200 ppm but not at 100 ppm. A 
significant area of uncertainty arising from the Nelson et al. (1943) study is the use of estimated 
rather than measured exposure concentrations.  Carpenter et al. (1975) evaluated eye irritation in 
7 human volunteers exposed for 15 minutes to 460, 1,000, 2,000, or 3,000 mg/m
3.  One volunteer 
noted mild throat discomfort at 460 mg/m
3, but not at 2,000 mg/m
3.  No subjects reported eye 
irritation at 460 mg/m
3 (106 ppm).  Hastings et al. (1984) exposed 50 healthy individuals to 100, 
200, or 400 ppm mixed xylenes for 30 minutes to evaluate eye, nose, and throat irritation.  The 
percent of subjects reporting eye irritation was 56 for controls (clean air), 60 at 100 ppm, 70 at 
200 ppm, and 90 at 400 ppm. The authors concluded there was no effect on eye irritation at 100 
ppm because the incidence of irritation was as low as the control group.  The data from Nelson et 
al (1943), Carpenter et al. (1975), and Hastings et al. (1984) taken together are consistent with a 
human NOAEL for eye irritation of about 100 ppm for at least a 30-minute exposure. 
Exposure of sedentary or exercising subjects to a 10-minute peak concentration of 400 ppm 
(1,736 mg/m³) resulted in significantly increased uncontrolled body sway in these subjects. 
Exposure to 200 ppm (868 mg/m³) xylene for up to 5 hours did not result in CNS disturbances 
measured by increased body sway (Laine et al., 1993).  Riihimaki and Savolainen (1980) reported 
that a single 5-minute exposure to 400 ppm xylene (isomeric form unknown) resulted in 
lightheadedness and inebriation similar to alcohol intoxication.  Deleterious effects on EEG, 
reaction time, body balance, and manual dexterity were found in 8 healthy volunteers following 
exposure to 100 ppm (434 mg/m³) m-xylene for 6 hours/day for 6 days (Savolainen et al., 1980). 
Exposure of 15 volunteers to 100 ppm technical xylene mixed with 20% ethylbenzene for 70 
minutes, including 30 minutes of exercise, resulted in significant impairments in short-term 
memory and other CNS performance tests (Gamberale et al., 1978).  Because ethylbenzene may 
have contributed to the CNS effects, definitive conclusions about the effects of xylene cannot be 
drawn from this study. 
Nine healthy male volunteers were exposed to 200 ppm m-xylene 4 hours a day, with or without 
exercise for 10 minutes at the beginning of each session (Savolainen et al., 1985).  There were no 
changes in reaction times, but average and maximal body sway were decreased in a concentration-
dependent manner.  Exercise had a sway reducing effect.  Male volunteers were exposed to 200 
ppm m-xylene vapor for 4 hours a day, either sedentary or with 10 minutes periods of exercise 
twice a day (Savolainen et al., 1984).  The body balance of the subjects was impaired in the 
anteroposterior direction.  Nine healthy male students were exposed to 200 ppm m-xylene for 4 
hours per day at 6-day intervals over 6 consecutive weeks (Savolainen et al., 1982).  Body sway 
tended to decrease with exposure.  Only minor electroencephalographic effects were noted on 4 
hour exposures to 200 ppm m-xylene exposure, and no other adverse effects were noted 
(Seppalainen et al., 1991). 
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Five volunteers were exposed to 40 ppm xylene for 7 hours/day, 3 consecutive days/week in an 
inhalation chamber.  There was an 11-day break between each 3-day session (Mergler and 
Beauvais, 1992).  Individual differences in olfactory perception thresholds for toluene were noted, 
but there was no effect of exposure duration. 
Predisposing Conditions for Xylene Toxicity 
Medical:  Unknown 
Chemical:  In rats, exposure to 300 ppm (1,302 mg/m³) m-xylene mixed with 600 ppm methyl 
ethyl ketone (MEK) for 6 hours resulted in synergistic effects on liver enzyme 
induction and glutathione depletion compared to MEK exposure alone (Liira et al., 
1991).  Xylene may therefore accelerate the metabolism and clearance of some 
other xenobiotics.  However, in the presence of MEK, xylene metabolism was 
strongly inhibited; this was accompanied by elevation of xylene concentrations in 
blood and fat.  Thus, exposure to xylene in the presence of other solvents may 
result in increased toxicity. 
V.  Acute Toxicity to Animals 
Six-hour inhalation LC50 values in mice for each xylene isomer are:  4,595, 5,267, and 3,907 ppm 
(19,942, 22,859, 16,956 mg/m³) for o-, m-, and p- xylene, respectively (Bonnet et al., 1979).  A 
4-hour LC50 for mixed xylenes was estimated as 6,700 ppm (29,078 mg/m³) in rats; and a 2-hour 
LC50 was calculated as 9,500 ppm (41,230 mg/m³) in cats (Carpenter et al., 1975). 
An increase in liver weight and cytochrome P450 (P450) content was observed in rats exposed to 
1,600 ppm (6,944 mg/m³) p-xylene for 6 hours (Simmons et al., 1991).  Rats exposed for 6-hours 
to 300 ppm (1,302 mg/m³) m-xylene showed increased specific liver P450 enzyme activity and 
depleted liver glutathione concentrations.  These effects were enhanced by simultaneous exposure 
to 600 ppm MEK (Liira et al., 1991). 
Pulmonary effects following exposure to 300 ppm (1,302 mg/m³) p-xylene for 6 hours include 
microsomal membrane damage and decreased lung P450 enzyme content (Silverman and Schatz, 
1991).  The destruction of rat lung but not liver P450 enzymes by p-xylene has been described by 
Patel et al. (1978), and has been attributed to the formation of a toxic aldehyde metabolite of p-
xylene.  Single 6-hr exposures of rats to m-xylene caused inhibition of aryl hydrocarbon 
hydroxylase and CYP2B1 activities in the lung but not the liver (Foy et al., 1996). 
VI.  Reproductive or Developmental Toxicity 
Exposure of pregnant rats for 6 hours/day on days 4-20 of gestation to 200 ppm (868 mg/m³) 
technical (mixed) xylene resulted in significantly increased incidence of delayed ossification of the 
skull in the offspring (Hass and Jakobsen, 1993).  The rat pups exposed prenatally to 200 ppm 
xylene displayed significantly decreased motor performance during adolescence.  However, a 
study using p-xylene showed no significant embryotoxic or developmental effects on the CNS as 
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measured by acoustic startle response in rats following exposure to 7,000 mg/m³ (1,613 ppm) 
throughout gestation (Rosen et al., 1986). 
All three isomers of xylene cause maternal toxicity and are fetotoxic but not teratogenic at near 
lethal concentrations in rats (Hudak and Ungvary, 1978; Ungvary et al., 1980).  Ungvary and 
Tatrai (1985) showed that exposure of both rats and mice to technical xylene as well as specific 
isomers resulted in fetotoxic effects such as fetal weight loss and delayed skeletal ossification.  Of 
the 3 isomers, p-xylene exposure is the most toxic to the fetus, since it results in the least maternal 
toxicity and the greatest fetotoxicity (Barlow and Sullivan, 1982); m-xylene has been shown to 
cause the greatest maternal toxicity (Hood and Ottley, 1985). 
Persistence of neurobehavioral effects was noted in offspring of female rats (Mol:WIST) exposed 
to 500 ppm technical xylene for 6 hours per day on days 7-20 of prenatal development.  The dose 
was not maternally toxic and did not decrease viability of offspring. Learning and memory abilities 
with spatial navigation on a water maze were impaired at 16, 28 and 55 weeks of age. However, 
differences were not significant at 55 weeks. The authors suggested these results were compatible 
with two different conclusions: 1) the effect was partly reversible over a long time period, or 2) 
practice at solving the problem led to compensation over unresolved neurotoxic effects (Hass et 
al., 1997).  Rats of the same strain (Mol: WIST) exposed prenatally to the same regimen did not 
show any differences from control rats in synaptosomal cytosolic calcium concentration (Edelfors 
et al., 1996). 
VII.	  Derivation of Acute Reference Exposure Level and Other Severity Levels 
(for a 1-hour exposure) 








Equivalent 1 hour concentration 
LOAEL uncertainty factor 
Interspecies uncertainty factor 
Intraspecies uncertainty factor 
Cumulative uncertainty factor 
Reference Exposure Level 
Hastings et al., 1984 (with support from Carpenter 
et al., 1975; Nelson et al., 1943) 
50 healthy human volunteers 
30 minute exposures to 430, 860 
or 1720 mg/m
3  xylene (technical grade) 




3 (100 ppm) 
30 minutes 
50 ppm (C





5 ppm (22 mg/m³, 22,000 mg/m³) 
With the possible exception of inconsistently observed developmental endpoints, irritation is the 
lowest reported human health effect for xylene. 
C - 357 - Xylenes Determination of Acute Reference Exposure Levels for Airborne Toxicants 
March 1999 
Level Protective Against Severe Adverse Effects 
No recommendation is made due to the limitations of the database. 
The NAS Committee on Toxicology (NRC, 1984) reviewed the toxicological literature for xylene 
and determined that the CNS was the main target for xylene toxicity.  The Committee concluded 
that the CNS disturbances in humans (Ogata et al., 1970; Gamberale et al., 1978) were reversible 
and were similar to those produced by alkyl benzenes and other related compounds.  Irritation of 
the eyes and mucous membranes (Carpenter et al., 1975; Nelson et al., 1943) was considered, but 
the purpose of the EEGL is to protect against CNS toxicity in military personnel .  Based on these 
findings, the Committee recommended a NAS-EEGL of 200 ppm (870 mg/m³).  However, it is 
not clear that an adequate margin of safety is incorporated into this EEGL for use for the general 
public. 
Level Protective Against Life-threatening Effects 
No recommendation is made due to the limitations of the database. 
The IDLH is 900 ppm, based on animal LC50 and LClo estimates divided by a 10-fold uncertainty 
factor (NIOSH, 1995).  The data cited include several 4 hour studies: (1) an 8,000 ppm m-xylene 
LClo for rats (Smyth et al., 1962); (2) a 4,550 ppm rat LC50 for p-xylene (Harper et al. 1977); and 
(3) a 5,000 ppm rat LC50 for xylenes (NPIRI, 1974).  The IDLH appears to be based on the 
Harper et al. (1977) data with an extrapolated 30-minute LC50 estimate of 9,100 ppm. 
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